{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:35:05Z","timestamp":1794047705775,"version":"4.8.0"},"reference-count":553,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.biomaterials.2020.120461","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T08:29:02Z","timestamp":1604651342000},"page":"120461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Treating brain diseases using systemic parenterally-administered protein therapeutics: Dysfunction of the brain barriers and potential strategies"],"prefix":"10.1016","volume":"269","author":[{"given":"A.","family":"Zaghmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Drouin-Ouellet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2020.120461_bib1","series-title":"Polymer-Protein Conjugates from PEGylation and beyond","first-page":"389","article-title":"In vivo properties of therapeutic bioconjugates composed of proteins and architecturally\/functionally complex polymers","author":"Zaghmi","year":"2019"},{"issue":"1\u20133","key":"10.1016\/j.biomaterials.2020.120461_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"22","key":"10.1016\/j.biomaterials.2020.120461_bib3","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.2174\/138161206777947722","article-title":"Structure and function of the intercellular junctions: barrier of paracellular drug delivery","volume":"12","author":"Zheng","year":"2006","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.biomaterials.2020.120461_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-61779-185-7_1","article-title":"Measuring size-dependent permeability of the tight junction using PEG profiling","volume":"762","author":"Van Itallie","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biomaterials.2020.120461_bib5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jconrel.2014.06.017","article-title":"Agile delivery of protein therapeutics to CNS","volume":"190","author":"Yi","year":"2014","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2020.120461_bib6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/bs.apha.2014.06.004","article-title":"Delivery of therapeutic peptides and proteins to the CNS","volume":"71","author":"Salameh","year":"2014","journal-title":"Adv. Pharmacol."},{"issue":"2\u20133","key":"10.1016\/j.biomaterials.2020.120461_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0169-409X(93)90048-9","article-title":"Delivery of peptides and proteins through the blood-brain-barrier","volume":"10","author":"Bickel","year":"1993","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib8","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1208\/s12248-015-9719-7","article-title":"Intranasal delivery of proteins and peptides in the treatment of neurodegenerative diseases","volume":"17","author":"Meredith","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.biomaterials.2020.120461_bib9","series-title":"Intranasal delivery of therapeutic peptides for treatment of ischemic brain injury","first-page":"65","author":"Huang","year":"2019"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11094-019-01960-x","article-title":"Molecular-biological problems of drug design and mechanism of drug action prospects for intranasal delivery of neuropeptides to the brain","volume":"53","author":"Shevchenko","year":"2019","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.biomaterials.2020.120461_bib11","article-title":"Das sauerstoff-bedurfnis des organismus","author":"Ehrlich","year":"1885","journal-title":"Eine farbenanalytische studie"},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120461_bib12","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.febslet.2014.02.060","article-title":"A new angle on blood-CNS interfaces: a role for connexins?","volume":"588","author":"De Bock","year":"2014","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrn2995","article-title":"Engaging neuroscience to advance translational research in brain barrier biology","volume":"12","author":"Neuwelt","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.biomaterials.2020.120461_bib14","series-title":"Molecular Biology of the Blood-Brain and the Blood-Cerebrospinal Fluid Barriers Similarities and Differences, Fluids Barriers CNS","author":"Redzic","year":"2011"},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib15","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1021\/mp300518e","article-title":"Physiology of blood-brain interfaces in relation to brain disposition of small compounds and macromolecules","volume":"10","author":"Strazielle","year":"2013","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1006995910836","article-title":"Tight junctions of the blood-brain barrier","volume":"20","author":"Kniesel","year":"2000","journal-title":"Cell. Mol. Neurobiol."},{"issue":"9","key":"10.1016\/j.biomaterials.2020.120461_bib17","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.2174\/1871527315666160915142244","article-title":"Tight junctions of the blood-brain barrier - a molecular gatekeeper","volume":"15","author":"Bauer","year":"2016","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"issue":"12","key":"10.1016\/j.biomaterials.2020.120461_bib18","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.addr.2004.07.005","article-title":"The structure of the choroid plexus and the physiology of the choroid plexus epithelium","volume":"56","author":"Redzic","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120461_bib19","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1517\/17425247.2016.1171315","article-title":"CSF, blood-brain barrier, and brain drug delivery","volume":"13","author":"Pardridge","year":"2016","journal-title":"Expet Opin. Drug Deliv."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120461_bib20","first-page":"1007","article-title":"The human ATP-binding cassette (ABC) transporter superfamily","volume":"42","author":"Dean","year":"2001","journal-title":"Genome Res."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib21","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1208\/s12248-017-0110-8","article-title":"SLC and ABC transporters: expression, localization, and species differences at the blood-brain and the blood-cerebrospinal fluid barriers","volume":"19","author":"Morris","year":"2017","journal-title":"AAPS J."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview","volume":"55","author":"Schinkel","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-0028-1103272","article-title":"ABC transporter (P-gp\/ABCB1, MRP1\/ABCC1, BCRP\/ABCG2) expression in the developing human CNS","volume":"39","author":"Daood","year":"2008","journal-title":"Neuropediatrics"},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib24","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/cne.21808","article-title":"Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces","volume":"510","author":"Gazzin","year":"2008","journal-title":"J. Comp. Neurol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Juliano","year":"1976","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.biomaterials.2020.120461_bib26","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1369\/jhc.5A6870.2006","article-title":"In situ localization of P-glycoprotein (ABCB1) in human and rat brain","volume":"54","author":"Bendayan","year":"2006","journal-title":"J. Histochem. Cytochem."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib27","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/pr.107.07109","article-title":"Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy","volume":"60","author":"Miller","year":"2008","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2045-8118-8-3","article-title":"Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences","volume":"8","author":"Redzic","year":"2011","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib29","doi-asserted-by":"crossref","first-page":"218s","DOI":"10.1093\/jn\/136.1.218S","article-title":"Structure of the blood-brain barrier and its role in the transport of amino acids","volume":"136","author":"Hawkins","year":"2006","journal-title":"J. Nutr."},{"key":"10.1016\/j.biomaterials.2020.120461_bib30","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1146\/annurev.biochem.78.081307.110540","article-title":"Mechanisms of endocytosis","volume":"78","author":"Doherty","year":"2009","journal-title":"Annu. Rev. Biochem."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1208\/s12248-008-9055-2","article-title":"CNS delivery via adsorptive transcytosis","volume":"10","author":"Herve","year":"2008","journal-title":"AAPS J."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib32","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ana.410010502","article-title":"The large apparent work capability of the blood-brain barrier: a study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat","volume":"1","author":"Oldendorf","year":"1977","journal-title":"Ann. Neurol."},{"issue":"46","key":"10.1016\/j.biomaterials.2020.120461_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201801362","article-title":"Overcoming the blood-brain barrier: the role of nanomaterials in treating neurological diseases","volume":"30","author":"Furtado","year":"2018","journal-title":"Adv. Mater."},{"issue":"1\u20133","key":"10.1016\/j.biomaterials.2020.120461_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0169-409X(95)00005-R","article-title":"Antibody delivery through the blood-brain-barrier","volume":"15","author":"Bickel","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"31","key":"10.1016\/j.biomaterials.2020.120461_bib35","doi-asserted-by":"crossref","first-page":"15214","DOI":"10.1016\/S0021-9258(18)48160-4","article-title":"Absorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport","volume":"262","author":"Kumagai","year":"1987","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib36","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1172\/JCI116825","article-title":"Protamine-mediated transport of albumin into brain and other organs of the rat - binding and endocytosis of protamine-albumin complex by microvascular endothelium","volume":"92","author":"Pardridge","year":"1993","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib37","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1046\/j.1471-4159.1996.66041599.x","article-title":"Polyamine modification increases the permeability of proteins at the blood-nerve and blood-brain barriers","volume":"66","author":"Poduslo","year":"1996","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.biomaterials.2020.120461_bib38","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.2174\/138920112803341851","article-title":"Adsorptive-mediated brain delivery systems","volume":"13","author":"Lu","year":"2012","journal-title":"Curr. Pharmaceut. Biotechnol."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib39","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016758","article-title":"Clathrin-independent pathways of endocytosis","volume":"6","author":"Mayor","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrm1593","article-title":"Organization of vesicular trafficking in epithelia","volume":"6","author":"Rodriguez-Boulan","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"Suppl 1","key":"10.1016\/j.biomaterials.2020.120461_bib41","first-page":"S9","article-title":"The endosomal network","volume":"47","author":"Brooks","year":"2009","journal-title":"Int. J Clin. Pharmaco.l Ther."},{"key":"10.1016\/j.biomaterials.2020.120461_bib42","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1146\/annurev.ph.52.030190.003135","article-title":"Exocytosis","volume":"52","author":"Almers","year":"1990","journal-title":"Annu. Rev. Physiol."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib43","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1471-4159.1985.tb05534.x","article-title":"Blood-brain barrier protein phosphorylation and dephosphorylation","volume":"45","author":"Pardridge","year":"1985","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biomaterials.2020.120461_bib44","series-title":"The Fine Structure of the Nervous System : Neurons and Their Supporting Cells","author":"Peters","year":"1991"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1006948027674","article-title":"Transferrin and transferrin receptor function in brain barrier systems","volume":"20","author":"Moos","year":"2000","journal-title":"Cell. Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib46","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/pr.54.4.561","article-title":"Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway","volume":"54","author":"Qian","year":"2002","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib47","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1517\/17425247.2.2.299","article-title":"Targeted delivery across the blood-brain barrier","volume":"2","author":"Gaillard","year":"2005","journal-title":"Expet Opin. Drug Deliv."},{"issue":"6005","key":"10.1016\/j.biomaterials.2020.120461_bib48","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/313756a0","article-title":"Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes","volume":"313","author":"Ullrich","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2020.120461_bib49","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1146\/annurev-pharmtox-010814-124852","article-title":"Targeting receptor-mediated transport for delivery of biologics across the blood-brain barrier","volume":"55","author":"Lajoie","year":"2015","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.biomaterials.2020.120461_bib50","volume":"vol. 14","author":"Melmed","year":"2019"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib51","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1471-4159.2008.05492.x","article-title":"Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector Angiopep-2","volume":"106","author":"Demeule","year":"2008","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib52","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1172\/JCI118891","article-title":"Identification of targets of leptin action in rat hypothalamus","volume":"98","author":"Schwartz","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"5383","key":"10.1016\/j.biomaterials.2020.120461_bib53","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1126\/science.281.5383.1683","article-title":"Biological action of leptin as an angiogenic factor","volume":"281","author":"Sierra-Honigmann","year":"1998","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib54","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1172\/JCI119125","article-title":"Human blood-brain barrier leptin receptor - binding and endocytosis in isolated human brain microvessels","volume":"99","author":"Golden","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120461_bib55","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1210\/endo.138.8.5343","article-title":"Expression and characterization of a putative high affinity human soluble leptin receptor","volume":"138","author":"Liu","year":"1997","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib56","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/1061186X.2016.1223676","article-title":"The potential use of rabies virus glycoprotein-derived peptides to facilitate drug delivery into the central nervous system: a mini review","volume":"25","author":"Huey","year":"2017","journal-title":"J. Drug Target."},{"key":"10.1016\/j.biomaterials.2020.120461_bib57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/bs.irn.2015.07.001","article-title":"Neuronal nicotinic acetylcholine receptor structure and function and response to nicotine","volume":"124","author":"Dani","year":"2015","journal-title":"Int. Rev. Neurobiol."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib58","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jmb.2004.12.031","article-title":"Refined structure of the nicotinic acetylcholine receptor at 4 angstrom resolution","volume":"346","author":"Unwin","year":"2005","journal-title":"J. Mol. Biol."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib59","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.tips.2014.12.002","article-title":"Nicotinic ACh receptors as therapeutic targets in CNS disorders","volume":"36","author":"Dineley","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biomaterials.2020.120461_bib60","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ics.2005.02.022","article-title":"Diphtheria toxin receptor-targeted brain drug delivery","volume":"1277","author":"Gaillard","year":"2005","journal-title":"Int Congr Ser"},{"issue":"11","key":"10.1016\/j.biomaterials.2020.120461_bib61","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/S0041-0101(01)00165-9","article-title":"Understanding the mode of action of diphtheria toxin: a perspective on progress during the 20th century","volume":"39","author":"Collier","year":"2001","journal-title":"Toxicon"},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib62","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3390\/toxins5061180","article-title":"Heparin-binding epidermal growth factor-like growth factor\/diphtheria toxin receptor in normal and neoplastic hematopoiesis","volume":"5","author":"Vinante","year":"2013","journal-title":"Toxins"},{"key":"10.1016\/j.biomaterials.2020.120461_bib63","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.addr.2015.02.005","article-title":"The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy","volume":"91","author":"Sockolosky","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib64","article-title":"Antibody transcytosis across brain endothelial-like cells occurs nonspecifically and independent of FcRn","volume":"10","author":"Ruano-Salguero","year":"2020","journal-title":"Sci Rep-Uk"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib65","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4155\/fmc.09.140","article-title":"Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders","volume":"2","author":"Mills","year":"2010","journal-title":"Future Med. Chem."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cbpc.2004.09.012","article-title":"Evolution of duplications in the transferrin family of proteins","volume":"140","author":"Lambert","year":"2005","journal-title":"Comp. Biochem. Physiol. B Biochem. Mol. Biol."},{"issue":"20","key":"10.1016\/j.biomaterials.2020.120461_bib67","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1007\/s00018-009-0051-1","article-title":"Mammalian iron transport","volume":"66","author":"Anderson","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biomaterials.2020.120461_bib68","first-page":"255","article-title":"The transferrin receptor","volume":"4","author":"Enns","year":"1996","journal-title":"Biomembranes: Multi-Vol. Treatise"},{"issue":"5440","key":"10.1016\/j.biomaterials.2020.120461_bib69","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1126\/science.286.5440.779","article-title":"Crystal structure of the ectodomain of human transferrin receptor","volume":"286","author":"Lawrence","year":"1999","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib70","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s004180050266","article-title":"Immunohistochemical localization of the murine transferrin receptor (TfR) on blood-tissue barriers using a novel anti-TfR monoclonal antibody","volume":"110","author":"Kissel","year":"1998","journal-title":"Histochem. Cell Biol."},{"issue":"Pt 4","key":"10.1016\/j.biomaterials.2020.120461_bib71","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/brain\/awr012","article-title":"Profile of altered brain iron acquisition in restless legs syndrome","volume":"134","author":"Connor","year":"2011","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib72","doi-asserted-by":"crossref","first-page":"10396","DOI":"10.1038\/s41598-017-11220-1","article-title":"Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma","volume":"7","author":"Johnsen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biomaterials.2020.120461_bib73","doi-asserted-by":"crossref","first-page":"101665","DOI":"10.1016\/j.pneurobio.2019.101665","article-title":"Targeting the transferrin receptor for brain drug delivery","volume":"181","author":"Johnsen","year":"2019","journal-title":"Prog. Neurobiol."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib74","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1046\/j.1471-4159.2003.02221.x","article-title":"Brain capillary endothelium and choroid plexus epithelium regulate transport of transferrin-bound and free iron into the rat brain","volume":"88","author":"Deane","year":"2004","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib75","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1021\/mp300518e","article-title":"Physiology of blood-brain interfaces in relation to brain disposition of small compounds and macromolecules","volume":"10","author":"Strazielle","year":"2013","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib76","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/pr.54.4.561","article-title":"Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway","volume":"54","author":"Qian","year":"2002","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib77","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuron.2013.10.061","article-title":"Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle","volume":"81","author":"Niewoehner","year":"2014","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096340","article-title":"A human blood-brain barrier transcytosis assay reveals antibody transcytosis influenced by pH-dependent receptor binding","volume":"9","author":"Sade","year":"2014","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib79","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/jnc.14482","article-title":"Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood-brain barrier in vitro is dependent on its binding affinity","volume":"146","author":"Haqqani","year":"2018","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.biomaterials.2020.120461_bib80","doi-asserted-by":"crossref","first-page":"5207","DOI":"10.1021\/acs.molpharmaceut.8b00730","article-title":"Blood-brain barrier transport, plasma pharmacokinetics, and neuropathology following chronic treatment of the rhesus monkey with a brain penetrating humanized monoclonal antibody against the human transferrin receptor","volume":"15","author":"Pardridge","year":"2018","journal-title":"Mol. Pharm."},{"issue":"261","key":"10.1016\/j.biomaterials.2020.120461_bib81","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009835","article-title":"Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates","volume":"6","author":"Yu","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"84","key":"10.1016\/j.biomaterials.2020.120461_bib82","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002230","article-title":"Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target","volume":"3","author":"Yu","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib83","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20131660","article-title":"Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants","volume":"211","author":"Nga","year":"2014","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib84","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1021\/acs.molpharmaceut.6b00051","article-title":"Dual functional peptide-driven nanoparticles for highly efficient glioma-targeting and drug codelivery","volume":"13","author":"Kuang","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2020.120461_bib85","doi-asserted-by":"crossref","first-page":"12651","DOI":"10.1038\/srep12651","article-title":"Enhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery system","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"issue":"183","key":"10.1016\/j.biomaterials.2020.120461_bib86","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005338","article-title":"Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrier","volume":"5","author":"Couch","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib87","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/10611860600650086","article-title":"Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies","volume":"14","author":"Smith","year":"2006","journal-title":"J. Drug Target."},{"key":"10.1016\/j.biomaterials.2020.120461_bib88","series-title":"Endotext","article-title":"Insulin biosynthesis, secretion, structure, and structure-activity relationships","author":"Weiss","year":"2000"},{"issue":"5739","key":"10.1016\/j.biomaterials.2020.120461_bib89","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/282623a0","article-title":"Insulin binds to brain blood vessels in vivo","volume":"282","author":"van Houten","year":"1979","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib90","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1210\/endo-117-3-1222","article-title":"Characterization of the receptors for insulin and the insulin-like growth factors on micro- and macrovascular tissues","volume":"117","author":"Jialal","year":"1985","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib91","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1210\/endo.132.3.8440175","article-title":"Ligand-binding properties of the two isoforms of the human insulin receptor","volume":"132","author":"Yamaguchi","year":"1993","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib92","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.str.2015.12.014","article-title":"Higher-Resolution structure of the human insulin receptor ectodomain: multi-modal inclusion of the insert domain","volume":"24","author":"Croll","year":"2016","journal-title":"Structure"},{"key":"10.1016\/j.biomaterials.2020.120461_bib93","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3389\/fnins.2019.00521","article-title":"Role of the blood-brain barrier in central nervous system insulin resistance","volume":"13","author":"Rhea","year":"2019","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib94","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1517\/17425247.2.2.299","article-title":"Targeted delivery across the blood-brain barrier","volume":"2","author":"Gaillard","year":"2005","journal-title":"Expet Opin. Drug Deliv."},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120461_bib95","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1007\/s00125-017-4285-4","article-title":"Unravelling the regulation of insulin transport across the brain endothelial cell","volume":"60","author":"Gray","year":"2017","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib96","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1023\/A:1016244500596","article-title":"Human insulin-receptor monoclonal-antibody undergoes high-affinity binding to human brain capillaries in-vitro and rapid transcytosis through the blood-brain-barrier in-vivo in the primate","volume":"12","author":"Pardridge","year":"1995","journal-title":"Pharmaceut. Res."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib97","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1023\/A:1016244500596","article-title":"Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate","volume":"12","author":"Pardridge","year":"1995","journal-title":"Pharmaceut. Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib98","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1023\/A:1007592720793","article-title":"Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor","volume":"17","author":"Coloma","year":"2000","journal-title":"Pharmaceut. Res."},{"issue":"21","key":"10.1016\/j.biomaterials.2020.120461_bib99","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.1073\/pnas.81.21.6851","article-title":"Chimeric human-antibody molecules - mouse antigen-binding domains with human constant region domains","volume":"81","author":"Morrison","year":"1984","journal-title":"Proc. Natl. Acad. Sci-Biol."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib100","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/bit.21120","article-title":"Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier","volume":"96","author":"Boado","year":"2007","journal-title":"Biotechnol. Bioeng."},{"issue":"4701","key":"10.1016\/j.biomaterials.2020.120461_bib101","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1126\/science.2988123","article-title":"The LDL receptor gene: a mosaic of exons shared with different proteins","volume":"228","author":"Sudhof","year":"1985","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib102","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0092-8674(84)90388-X","article-title":"Domain map of the LDL receptor: sequence homology with the epidermal growth factor precursor","volume":"37","author":"Russell","year":"1984","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib103","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0092-8674(84)90188-0","article-title":"The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA","volume":"39","author":"Yamamoto","year":"1984","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.biomaterials.2020.120461_bib104","doi-asserted-by":"crossref","first-page":"15261","DOI":"10.1016\/S0021-9258(17)43802-6","article-title":"Biosynthesis of N- and O-linked oligosaccharides of the low density lipoprotein receptor","volume":"258","author":"Cummings","year":"1983","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0092-8674(86)90533-7","article-title":"The J.D. mutation in familial hypercholesterolemia: amino acid substitution in cytoplasmic domain impedes internalization of LDL receptors","volume":"45","author":"Davis","year":"1986","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib106","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1016\/S0021-9258(19)39742-X","article-title":"Npxy, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low-density-lipoprotein receptor","volume":"265","author":"Chen","year":"1990","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib107","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1083\/jcb.117.1.39","article-title":"Cytoplasmic sequence required for basolateral targeting of ldl receptor in livers of transgenic mice","volume":"117","author":"Yokode","year":"1992","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biomaterials.2020.120461_bib108","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.biochem.71.110601.135342","article-title":"Lipoprotein receptors in the nervous system","volume":"71","author":"Herz","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.biomaterials.2020.120461_bib109","first-page":"4536302","article-title":"The roles of low-density lipoprotein receptor-related proteins 5, 6, and 8 in cancer: a review","author":"Roslan","year":"2019","journal-title":"J. Oncol."},{"key":"10.1016\/j.biomaterials.2020.120461_bib110","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.nutr.19.1.141","article-title":"The mammalian low-density lipoprotein receptor family","volume":"19","author":"Hussain","year":"1999","journal-title":"Annu. Rev. Nutr."},{"issue":"6 Pt 2","key":"10.1016\/j.biomaterials.2020.120461_bib111","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1083\/jcb.109.6.3303","article-title":"Iterative fractionation of recycling receptors from lysosomally destined ligands in an early sorting endosome","volume":"109","author":"Dunn","year":"1989","journal-title":"J. Cell Biol."},{"issue":"32","key":"10.1016\/j.biomaterials.2020.120461_bib112","doi-asserted-by":"crossref","first-page":"28537","DOI":"10.1074\/jbc.M203989200","article-title":"Effects of lipoprotein lipase on uptake and transcytosis of low density lipoprotein (LDL) and LDL-associated alpha-tocopherol in a porcine in vitro blood-brain barrier model","volume":"277","author":"Goti","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib113","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1083\/jcb.126.2.465","article-title":"Upregulation of the low density lipoprotein receptor at the blood-brain barrier: intercommunications between brain capillary endothelial cells and astrocytes","volume":"126","author":"Dehouck","year":"1994","journal-title":"J. Cell Biol."},{"issue":"5\u20136","key":"10.1016\/j.biomaterials.2020.120461_bib114","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/10623320802487759","article-title":"Physiological pathway for low-density lipoproteins across the blood-brain barrier: transcytosis through brain capillary endothelial cells in vitro","volume":"15","author":"Candela","year":"2008","journal-title":"Endothelium"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib115","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1083\/jcb.138.4.877","article-title":"A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier","volume":"138","author":"Dehouck","year":"1997","journal-title":"J. Cell Biol."},{"issue":"5\u20136","key":"10.1016\/j.biomaterials.2020.120461_bib116","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/10623320802487759","article-title":"Physiological pathway for low-density lipoproteins across the blood-brain barrier: transcytosis through brain capillary endothelial cells in vitro","volume":"15","author":"Candela","year":"2008","journal-title":"Endothelium-J Endoth"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib117","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00441-008-0688-3","article-title":"Endothelial transcytosis in health and disease","volume":"335","author":"Simionescu","year":"2009","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.biomaterials.2020.120461_bib118","doi-asserted-by":"crossref","first-page":"34297","DOI":"10.1038\/srep34297","article-title":"Presumed LRP1-targeting transport peptide delivers beta-secretase inhibitor to neurons in vitro with limited efficiency","volume":"6","author":"Kim","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib119","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120461_bib120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130442","article-title":"Nano-drugs based on nano sterically stabilized liposomes for the treatment of inflammatory neurodegenerative diseases","volume":"10","author":"Turjeman","year":"2015","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib121","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib122","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib123","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.nbd.2005.06.012","article-title":"Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis","volume":"20","author":"Vos","year":"2005","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib124","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1155\/2006\/709869","article-title":"Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis","volume":"22","author":"Waubant","year":"2006","journal-title":"Dis. Markers"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1602\/neurorx.2.2.277","article-title":"Imaging of multiple sclerosis: role in neurotherapeutics","volume":"2","author":"Bakshi","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.biomaterials.2020.120461_bib126","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/brain\/113.5.1477","article-title":"Breakdown of the blood-brain-barrier precedes symptoms and other mri signs of new lesions in multiple-sclerosis - pathogenetic and clinical implications","volume":"113","author":"Kermode","year":"1990","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib127","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF00296505","article-title":"Evidence of persistent blood-brain-barrier abnormalities in chronic-progressive multiple-sclerosis","volume":"90","author":"Claudio","year":"1995","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib128","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1212\/WNL.40.2.229","article-title":"Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement","volume":"40","author":"Kermode","year":"1990","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib129","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1148\/radiology.169.1.3420246","article-title":"Multiple sclerosis: serial study of gadolinium-enhanced MR imaging","volume":"169","author":"Grossman","year":"1988","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.biomaterials.2020.120461_bib130","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrn1807","article-title":"Metalloproteinases: mediators of pathology and regeneration in the CNS","volume":"6","author":"Yong","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"issue":"12","key":"10.1016\/j.biomaterials.2020.120461_bib131","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1474-4422(03)00587-8","article-title":"Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis","volume":"2","author":"Opdenakker","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biomaterials.2020.120461_bib132","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1093\/brain\/awg285","article-title":"Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis","volume":"126","author":"Bar-Or","year":"2003","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib133","doi-asserted-by":"crossref","DOI":"10.4161\/tisb.24782","article-title":"Regulation of claudins in blood-tissue barriers under physiological and pathological states","volume":"1","author":"Goncalves","year":"2013","journal-title":"Tissue Barriers"},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib134","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00401-011-0883-2","article-title":"Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis","volume":"122","author":"Pfeiffer","year":"2011","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib135","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00401-003-0688-z","article-title":"Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme","volume":"105","author":"Wolburg","year":"2003","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib136","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.neuroscience.2007.04.051","article-title":"Inflammation and dephosphorylation of the tight junction protein occludin in an experimental model of multiple sclerosis","volume":"147","author":"Morgan","year":"2007","journal-title":"Neuroscience"},{"issue":"34","key":"10.1016\/j.biomaterials.2020.120461_bib137","doi-asserted-by":"crossref","first-page":"9032","DOI":"10.1523\/JNEUROSCI.2088-07.2007","article-title":"Angiotensin II controls occludin function and is required for blood-brain barrier maintenance: relevance to multiple sclerosis","volume":"27","author":"Wosik","year":"2007","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib138","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.0808698106","article-title":"VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown","volume":"106","author":"Argaw","year":"2009","journal-title":"Proc. Natl. Acad. Sci-Biol."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib139","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/path.1434","article-title":"Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination","volume":"201","author":"Kirk","year":"2003","journal-title":"J. Pathol."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib140","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1191\/1352458503ms916oa","article-title":"Serum from patients with multiple sclerosis downregulates occludin and VE-cadherin expression in cultured endothelial cells","volume":"9","author":"Minagar","year":"2003","journal-title":"Mult. Scler."},{"issue":"15\u201316","key":"10.1016\/j.biomaterials.2020.120461_bib141","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.drudis.2006.06.008","article-title":"The impact of interferon-beta treatment on the blood-brain barrier","volume":"11","author":"Kraus","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biomaterials.2020.120461_bib142","first-page":"65","article-title":"Multiple sclerosis: overview of disease-modifying agents","volume":"6","author":"Finkelsztejn","year":"2014","journal-title":"Perspect. Med. Chem."},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120461_bib143","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tins.2011.05.006","article-title":"Clarifying lysosomal storage diseases","volume":"34","author":"Schultz","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.biomaterials.2020.120461_bib144","article-title":"The mucopolysaccharidoses: a success of molecular medicine (vol 10, e1","volume":"11","author":"Clarke","year":"2008","journal-title":"Expet Rev. Mol. Med."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib145","doi-asserted-by":"crossref","DOI":"10.1590\/S1415-47572010005000093","article-title":"II, and VI: brief review and guidelines for treatment","volume":"33","author":"Giugliani","year":"2010","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.biomaterials.2020.120461_bib146","doi-asserted-by":"crossref","DOI":"10.1186\/s13052-018-0553-2","article-title":"Biochemical and molecular analysis in mucopolysaccharidoses: what a paediatrician must know","volume":"44","author":"Filocamo","year":"2018","journal-title":"Ital. J. Pediatr."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib147","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.nbd.2006.09.005","article-title":"IgG entry and deposition are components of the neuroimmune response in Batten disease","volume":"25","author":"Lim","year":"2007","journal-title":"Neurobiol. Dis."},{"issue":"Pt 4","key":"10.1016\/j.biomaterials.2020.120461_bib148","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/brain\/awg089","article-title":"Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis","volume":"126","author":"Jeyakumar","year":"2003","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib149","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016601","article-title":"Blood-brain barrier impairment in an animal model of MPS III B","volume":"6","author":"Garbuzova-Davis","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.biomaterials.2020.120461_bib150","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1471-2377-13-174","article-title":"Blood-brain barrier impairment in MPS III patients","volume":"13","author":"Garbuzova-Davis","year":"2013","journal-title":"BMC Neurol."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib151","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016601","article-title":"Blood-brain barrier impairment in an animal model of MPS III B","volume":"6","author":"Garbuzova-Davis","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.biomaterials.2020.120461_bib152","series-title":"Lysosomal Storage Disorders: a Practical Guide","author":"Mehta","year":"2012"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib153","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.beem.2014.12.001","article-title":"Neuronopathic lysosomal storage disorders: approaches to treat the central nervous system","volume":"29","author":"Scarpa","year":"2015","journal-title":"Best Pract. Res. Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib154","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ymgme.2011.01.015","article-title":"Neuroinflammatory and oxidative stress phenomena in MPS IIIA mouse model: the positive effect of long-term aspirin treatment","volume":"103","author":"Arfi","year":"2011","journal-title":"Mol. Genet. Metabol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib155","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1742-2094-7-39","article-title":"Mucopolysaccharidosis IIIB, a lysosomal storage disease, triggers a pathogenic CNS autoimmune response","volume":"7","author":"Killedar","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.biomaterials.2020.120461_bib156","series-title":"Acute Stroke (Cerebrovascular Accident), StatPearls, Treasure Island (FL)","author":"Tadi","year":"2020"},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib157","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.neuron.2014.03.003","article-title":"Stepwise recruitment of transcellular and paracellular pathways underlies blood-brain barrier breakdown in stroke","volume":"82","author":"Knowland","year":"2014","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib158","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/STROKEAHA.114.007445","article-title":"Blood-brain barrier KCa3.1 channels: evidence for a role in brain Na uptake and edema in ischemic stroke","volume":"46","author":"Chen","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.biomaterials.2020.120461_bib159","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/bs.apha.2014.06.011","article-title":"Blood-brain barrier Na transporters in ischemic stroke","volume":"71","author":"O'Donnell","year":"2014","journal-title":"Adv. Pharmacol."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib160","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/jcbfm.2012.160","article-title":"Intravenous HOE-642 reduces brain edema and Na uptake in the rat permanent middle cerebral artery occlusion model of stroke: evidence for participation of the blood-brain barrier Na\/H exchanger","volume":"33","author":"O'Donnell","year":"2013","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib161","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12975-015-0439-1","article-title":"Fluid intake related to brain edema in acute middle cerebral artery infarction","volume":"7","author":"Dharmasaroja","year":"2016","journal-title":"Transl. Stroke Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib162","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/0271678X15617172","article-title":"Molecular pathophysiology of cerebral edema","volume":"36","author":"Stokum","year":"2016","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib163","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0033-0620(99)70003-4","article-title":"Ischemic brain edema","volume":"42","author":"Rosenberg","year":"1999","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib164","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/jon.12225","article-title":"Early blood brain barrier changes in acute ischemic stroke: a sequential MRI study","volume":"25","author":"Giraud","year":"2015","journal-title":"J. Neuroimaging"},{"issue":"21","key":"10.1016\/j.biomaterials.2020.120461_bib165","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1111\/febs.13412","article-title":"The dynamic blood-brain barrier","volume":"282","author":"Keaney","year":"2015","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib166","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-brain barrier: from physiology to disease and back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiol. Rev."},{"issue":"11","key":"10.1016\/j.biomaterials.2020.120461_bib167","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1038\/jcbfm.2009.106","article-title":"Cerebral ischemia-reperfusion injury in rats-A 3 T MRI study on biphasic blood-brain barrier opening and the dynamics of edema formation","volume":"29","author":"Pillai","year":"2009","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib168","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.nbd.2008.08.005","article-title":"Blood-brain barrier tight junction permeability and ischemic stroke","volume":"32","author":"Sandoval","year":"2008","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib169","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-510X(99)00121-5","article-title":"Dynamics of cerebral injury, perfusion, and blood-brain barrier changes after temporary and permanent middle cerebral artery occlusion in the rat","volume":"166","author":"Kastrup","year":"1999","journal-title":"J. Neurol. Sci."},{"issue":"12","key":"10.1016\/j.biomaterials.2020.120461_bib170","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1161\/01.STR.0000190000.98707.6d","article-title":"Inhibition of brain GTP cyclohydrolase I and tetrahydrobiopterin attenuates cerebral infarction via reducing inducible NO synthase and peroxynitrite in ischemic stroke","volume":"36","author":"Kidd","year":"2005","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib171","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/jcbfm.2013.169","article-title":"Stroke-induced brain parenchymal injury drives blood-brain barrier early leakage kinetics: a combined in vivo\/in vitro study","volume":"34","author":"Kuntz","year":"2014","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.biomaterials.2020.120461_bib172","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.brainres.2009.05.025","article-title":"Post-ischemic blood-brain barrier leakage in rats: one-week follow-up by MRI","volume":"1280","author":"Durukan","year":"2009","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib173","first-page":"541","article-title":"Transferrin receptor mediated brain uptake during ischemia and reperfusion","volume":"16","author":"Hao","year":"2013","journal-title":"J. Pharm. Pharmaceut. Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib174","first-page":"59","article-title":"Upregulation of lipoprotein receptors on brain endothelial cells and neurons in the early phase of ischemic stroke in mice","volume":"65","author":"Li","year":"2018","journal-title":"J. Med. Dent. Sci."},{"issue":"15","key":"10.1016\/j.biomaterials.2020.120461_bib175","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1182\/blood-2009-02-203919","article-title":"Tissue-type plasminogen activator (t-PA) induces stromelysin-1 (MMP-3) in endothelial cells through activation of lipoprotein receptor-related protein","volume":"114","author":"Suzuki","year":"2009","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.biomaterials.2020.120461_bib176","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1038\/jcbfm.2015.167","article-title":"Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in mice","volume":"35","author":"Suzuki","year":"2015","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib177","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.nbd.2008.08.005","article-title":"Blood-brain barrier tight junction permeability and ischemic stroke","volume":"32","author":"Sandoval","year":"2008","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib178","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2045-8118-9-23","article-title":"Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation","volume":"9","author":"Luissint","year":"2012","journal-title":"Fluids Barriers CNS"},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib179","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/sj.jcbfm.9600224","article-title":"The effects of cerebral ischemia on the rat choroid plexus","volume":"26","author":"Ennis","year":"2006","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib180","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/1097-0029(20010101)52:1<130::AID-JEMT14>3.0.CO;2-6","article-title":"Cell death in the choroid plexus following transient forebrain global ischemia in the rat","volume":"52","author":"Ferrand-Drake","year":"2001","journal-title":"Microsc. Res. Tech."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib181","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1023\/A:1007097622590","article-title":"Choroid plexus recovery after transient forebrain ischemia: role of growth factors and other repair mechanisms","volume":"20","author":"Johanson","year":"2000","journal-title":"Cell. Mol. Neurobiol."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2020.120461_bib182","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(95)00520-Z","article-title":"Cystatin C, a protease inhibitor, in degenerating rat hippocampal neurons following transient forebrain ischemia","volume":"691","author":"Palm","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.biomaterials.2020.120461_bib183","series-title":"Blood-Spinal Cord and Brain Barriers in Health and Disease","author":"Johanson","year":"2003"},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib184","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40259-017-0248-z","article-title":"Delivery of biologics across the blood-brain barrier with molecular trojan horse technology","volume":"31","author":"Pardridge","year":"2017","journal-title":"BioDrugs"},{"key":"10.1016\/j.biomaterials.2020.120461_bib185","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3389\/fncel.2019.00528","article-title":"Traumatic brain injuries: pathophysiology and potential therapeutic targets","volume":"13","author":"Ng","year":"2019","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib186","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3940(97)00239-5","article-title":"The biphasic opening of the blood-brain barrier in the cortex and hippocampus after traumatic brain injury in rats","volume":"226","author":"Baskaya","year":"1997","journal-title":"Neurosci. Lett."},{"issue":"22","key":"10.1016\/j.biomaterials.2020.120461_bib187","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1089\/neu.2014.3861","article-title":"Pre-clinical traumatic brain injury common data elements: toward a common language across laboratories","volume":"32","author":"Smith","year":"2015","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.biomaterials.2020.120461_bib188","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/B978-0-444-52892-6.00004-0","article-title":"The neuropathology of traumatic brain injury","volume":"127","author":"McKee","year":"2015","journal-title":"Handb. Clin. Neurol."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120461_bib189","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrneurol.2010.74","article-title":"Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury","volume":"6","author":"Shlosberg","year":"2010","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib190","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3109\/02699052.2015.1080386","article-title":"Protective effect of rhEPO on tight junctions of cerebral microvascular endothelial cells early following traumatic brain injury in rats","volume":"30","author":"Qian","year":"2016","journal-title":"Brain Inj."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib191","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3892\/etm.2014.1818","article-title":"Overexpression of netrin-1 increases the expression of tight junction-associated proteins, claudin-5, occludin, and ZO-1, following traumatic brain injury in rats","volume":"8","author":"Wen","year":"2014","journal-title":"Exp. Ther. Med."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib192","first-page":"1137","article-title":"Molecular mechanisms in the pathogenesis of traumatic brain injury","volume":"17","author":"Ray","year":"2002","journal-title":"Histol. Histopathol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib193","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.nurt.2009.10.022","article-title":"Clinical trials in traumatic brain injury: past experience and current developments","volume":"7","author":"Maas","year":"2010","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib194","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1089\/089771502753754037","article-title":"Clinical trials in head injury","volume":"19","author":"Narayan","year":"2002","journal-title":"J. Neurotrauma"},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib195","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","article-title":"Alzheimer's disease facts and figures","volume":"15","author":"Gaugler","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib196","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction","volume":"25","author":"Nation","year":"2019","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib197","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1750-3639.2012.00628.x","article-title":"Vascular degeneration in Parkinson's disease","volume":"23","author":"Guan","year":"2013","journal-title":"Brain Pathol."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib198","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/jcbfm.2015.32","article-title":"Striatal blood-brain barrier permeability in Parkinson's disease","volume":"35","author":"Gray","year":"2015","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib199","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.24406","article-title":"Cerebrovascular and blood-brain barrier impairments in Huntington's disease: potential implications for its pathophysiology","volume":"78","author":"Drouin-Ouellet","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biomaterials.2020.120461_bib200","doi-asserted-by":"crossref","first-page":"807356","DOI":"10.1155\/2012\/807356","article-title":"Modulation of tight junction structure and function by kinases and phosphatases targeting occludin","volume":"2012","author":"Dorfel","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib201","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/MCB.06029-11","article-title":"Occludin: one protein, many forms","volume":"32","author":"Cummins","year":"2012","journal-title":"Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib202","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1471-4159.2009.06319.x","article-title":"The blood-brain barrier in neurodegenerative disease: a rhetorical perspective","volume":"111","author":"Carvey","year":"2009","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.biomaterials.2020.120461_bib203","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092693","article-title":"The \"frail\" brain blood barrier in neurodegenerative diseases: role of early disruption of endothelial cell-to-cell connections","volume":"19","author":"Maiuolo","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biomaterials.2020.120461_bib204","article-title":"Role of the blood-brain barrier in central nervous system insulin resistance","volume":"13","author":"Rhea","year":"2019","journal-title":"Front Neurosci-Switz"},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2020.120461_bib205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0006-8993(92)91193-I","article-title":"Transferrin receptors of rat and human brain and cerebral microvessels and their status in alzheimers-disease","volume":"585","author":"Kalaria","year":"1992","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib206","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2990.1994.tb00998.x","article-title":"Transferrin receptors in the normal human Hippocampus and in alzheimers-disease","volume":"20","author":"Morris","year":"1994","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib207","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0006-8993(96)01412-6","article-title":"The density of [I-125]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease","volume":"749","author":"Faucheux","year":"1997","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib208","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1111\/j.1471-4159.1993.tb03527.x","article-title":"Distribution of I-125 ferrotransferrin binding-sites in the mesencephalon of control subjects and patients with Parkinsons-disease","volume":"60","author":"Faucheux","year":"1993","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib209","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2990.1994.tb00997.x","article-title":"Transferrin receptors in the parkinsonian midbrain","volume":"20","author":"Morris","year":"1994","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib210","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neuron.2015.09.036","article-title":"Lack of widespread BBB disruption in Alzheimer's disease models: focus on therapeutic antibodies","volume":"88","author":"Bien-Ly","year":"2015","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib211","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1021\/acs.molpharmaceut.8b00870","article-title":"Transferrin receptor-mediated uptake at the blood-brain barrier is not impaired by Alzheimer's disease neuropathology","volume":"16","author":"Bourassa","year":"2019","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib212","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","article-title":"RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease","volume":"112","author":"Donahue","year":"2006","journal-title":"Acta Neuropathol."},{"issue":"12","key":"10.1016\/j.biomaterials.2020.120461_bib213","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib214","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1212\/WNL.50.1.164","article-title":"Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype","volume":"50","author":"Craft","year":"1998","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib215","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biomaterials.2020.120461_bib216","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.brainres.2010.08.034","article-title":"ABC efflux transporters in brain vasculature of Alzheimer's subjects","volume":"1358","author":"Wijesuriya","year":"2010","journal-title":"Brain Res."},{"issue":"Pt 1","key":"10.1016\/j.biomaterials.2020.120461_bib217","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/brain\/awr298","article-title":"Blood-brain barrier P-glycoprotein function in Alzheimer's disease","volume":"135","author":"van Assema","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.biomaterials.2020.120461_bib218","doi-asserted-by":"crossref","first-page":"S515","DOI":"10.2741\/1085","article-title":"Choroid plexus, ageing of the brain, and Alzheimer's disease","volume":"8","author":"Serot","year":"2003","journal-title":"Front Biosci-Landmrk"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib219","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/JAD-2012-111964","article-title":"A possible role for CSF turnover and choroid plexus in the pathogenesis of late onset Alzheimer's disease","volume":"30","author":"Serot","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.biomaterials.2020.120461_bib220","doi-asserted-by":"crossref","DOI":"10.1186\/s12864-015-2159-z","article-title":"Gene expression and functional annotation of human choroid plexus epithelium failure in Alzheimer's disease","volume":"16","author":"Bergen","year":"2015","journal-title":"BMC Genom."},{"issue":"37","key":"10.1016\/j.biomaterials.2020.120461_bib221","doi-asserted-by":"crossref","first-page":"12766","DOI":"10.1523\/JNEUROSCI.0006-15.2015","article-title":"Amyloid beta oligomers disrupt blood-CSF barrier integrity by activating matrix metalloproteinases","volume":"35","author":"Brkic","year":"2015","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib222","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib223","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1038\/s41598-019-42456-8","article-title":"Cell-penetrating peptide sequence and modification dependent uptake and subcellular distribution of green florescent protein in different cell lines","volume":"9","author":"Patel","year":"2019","journal-title":"Sci. Rep."},{"issue":"25","key":"10.1016\/j.biomaterials.2020.120461_bib224","doi-asserted-by":"crossref","first-page":"16010","DOI":"10.1074\/jbc.272.25.16010","article-title":"A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus","volume":"272","author":"Vives","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib225","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1046\/j.1432-1327.2001.01997.x","article-title":"Physico-chemical requirements for cellular uptake of pAntp peptide. Role of lipid-binding affinity","volume":"268","author":"Drin","year":"2001","journal-title":"Eur. J. Biochem."},{"issue":"24","key":"10.1016\/j.biomaterials.2020.120461_bib226","doi-asserted-by":"crossref","first-page":"13003","DOI":"10.1073\/pnas.97.24.13003","article-title":"The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters","volume":"97","author":"Wender","year":"2000","journal-title":"Proc. Natl. Acad. Sci-Biol."},{"issue":"12","key":"10.1016\/j.biomaterials.2020.120461_bib227","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.febslet.2013.04.031","article-title":"Cell\u2010penetrating peptides: 20 years later, where do we stand?","volume":"587","author":"Bechara","year":"2013","journal-title":"FEBS Lett."},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120461_bib228","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1096\/fj.00-0780fje","article-title":"Cellular translocation of proteins by transportan","volume":"15","author":"Pooga","year":"2001","journal-title":"Faseb. J."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib229","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0005-2736(01)00398-4","article-title":"Cargo delivery kinetics of cell-penetrating peptides","volume":"1515","author":"Hallbrink","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biomaterials.2020.120461_bib230","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/B978-0-12-814001-7.00007-X","article-title":"Brain drug delivery by adsorption-mediated transcytosis","author":"Zhu","year":"2019","journal-title":"Brain Targeted Drug Delivery Syst."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib231","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0005-2736(02)00471-6","article-title":"A quantitative validation of fluorophore-labelled cell-permeable peptide conjugates: fluorophore and cargo dependence of import","volume":"1564","author":"Fischer","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biomaterials.2020.120461_bib232","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.biopha.2018.09.097","article-title":"Cell penetrating peptides: a concise review with emphasis on biomedical applications","volume":"108","author":"Derakhshankhah","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib233","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/10717544.2011.567310","article-title":"Cell-penetrating TAT peptide in drug delivery systems: proteolytic stability requirements","volume":"18","author":"Koren","year":"2011","journal-title":"Drug Deliv."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib234","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.1208\/ps040426","article-title":"Peptide delivery to the brain via adsorptive-mediated endocytosis: advances with SynB vectors","volume":"4","author":"Drin","year":"2002","journal-title":"AAPS PharmSci"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib235","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejpb.2004.02.018","article-title":"Chances and pitfalls of cell penetrating peptides for cellular drug delivery","volume":"58","author":"Trehin","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib236","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1124\/jpet.102.048520","article-title":"Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy","volume":"306","author":"Rousselle","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib237","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/10611860290031886","article-title":"Improved brain delivery of benzylpenicillin with a peptide-vector-mediated strategy","volume":"10","author":"Rousselle","year":"2002","journal-title":"J. Drug Target."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib238","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0955-0674(00)00108-3","article-title":"Messenger proteins: homeoproteins, TAT and others","volume":"12","author":"Prochiantz","year":"2000","journal-title":"Curr. Opin. Cell Biol."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib239","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1083\/jcb.121.2.461","article-title":"A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin","volume":"121","author":"Vogel","year":"1993","journal-title":"J. Cell Biol."},{"issue":"10","key":"10.1016\/j.biomaterials.2020.120461_bib240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139652","article-title":"Cell-penetrating peptides selectively cross the blood-brain barrier in vivo","volume":"10","author":"Stalmans","year":"2015","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib241","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/1570159X11311020006","article-title":"Cell-penetrating Peptide-mediated therapeutic molecule delivery into the central nervous system","volume":"11","author":"Zou","year":"2013","journal-title":"Curr. Neuropharmacol."},{"issue":"5433","key":"10.1016\/j.biomaterials.2020.120461_bib242","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","article-title":"In vivo protein transduction: delivery of a biologically active protein into the mouse","volume":"285","author":"Schwarze","year":"1999","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib243","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1073\/pnas.91.2.664","article-title":"Tat-mediated delivery of heterologous proteins into cells","volume":"91","author":"Fawell","year":"1994","journal-title":"Proc. Natl. Acad. Sci-Biol."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib244","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/01.STR.0000066869.45310.50","article-title":"Intravenous TAT-GDNF is protective after focal cerebral ischemia in mice","volume":"34","author":"Kilic","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.biomaterials.2020.120461_bib245","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainres.2006.01.083","article-title":"Application of a blood-brain-barrier-penetrating form of GDNF in a mouse model for Parkinson's disease","volume":"1082","author":"Dietz","year":"2006","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib246","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/jcbfm.2009.44","article-title":"TAT-Hsp70-mediated neuroprotection and increased survival of neuronal precursor cells after focal cerebral ischemia in mice","volume":"29","author":"Doeppner","year":"2009","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"13","key":"10.1016\/j.biomaterials.2020.120461_bib247","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1523\/JNEUROSCI.22-13-05423.2002","article-title":"In vivo delivery of a bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis","volume":"22","author":"Cao","year":"2002","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib248","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ana.10356","article-title":"Intravenous TAT-Bcl-Xl is protective after middle cerebral artery occlusion in mice","volume":"52","author":"Kilic","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biomaterials.2020.120461_bib249","doi-asserted-by":"crossref","DOI":"10.1016\/j.neures.2011.07.447","article-title":"TAT-mediated delivery of neuroglobin protects against focal cerebral ischemia in mice","volume":"71","author":"Cai","year":"2011","journal-title":"Neurosci. Res."},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120461_bib250","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3109\/1061186X.2010.523788","article-title":"Targeted delivery of large fusion protein into hippocampal neurons by systemic administration","volume":"19","author":"Xiang","year":"2011","journal-title":"J. Drug Target."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib251","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1007\/s11095-012-0667-y","article-title":"Targeted delivery of proteins into the central nervous system mediated by rabies virus glycoprotein-derived peptide","volume":"29","author":"Fu","year":"2012","journal-title":"Pharmaceut. Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib252","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1208\/s12248-008-9055-2","article-title":"CNS delivery via adsorptive transcytosis","volume":"10","author":"Herve","year":"2008","journal-title":"AAPS J."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120461_bib253","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1021\/bc800148t","article-title":"Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses","volume":"19","author":"Pardridge","year":"2008","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.biomaterials.2020.120461_bib254","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/B978-0-12-396962-0.00011-2","article-title":"Reengineering biopharmaceuticals for targeted delivery across the blood\u2013brain barrier","author":"Pardridge","year":"2012","journal-title":"Methods Enzymol."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib255","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1046\/j.1471-4159.2001.00222.x","article-title":"Rapid transferrin efflux from brain to blood across the blood-brain barrier","volume":"76","author":"Zhang","year":"2001","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib256","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0022-3565(24)35388-1","article-title":"Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse","volume":"292","author":"Lee","year":"2000","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib257","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0022-3565(25)20567-5","article-title":"Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo","volume":"259","author":"Pardridge","year":"1991","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib258","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/exnr.1996.0178","article-title":"Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor","volume":"142","author":"Broadwell","year":"1996","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib259","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/bit.22135","article-title":"Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood-brain barrier delivery in the mouse","volume":"102","author":"Boado","year":"2009","journal-title":"Biotechnol. Bioeng."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib260","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3109\/10611860008997916","article-title":"Cloning and expression in pichia pastoris of a genetically engineered single chain antibody against the rat transferrin receptor","volume":"8","author":"Boado","year":"2000","journal-title":"J. Drug Target."},{"issue":"9","key":"10.1016\/j.biomaterials.2020.120461_bib261","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/protein\/12.9.787","article-title":"Genetically engineered brain drug delivery vectors: cloning, expression and in vivo application of an anti-transferrin receptor single chain antibody-streptavidin fusion gene and protein","volume":"12","author":"Li","year":"1999","journal-title":"Protein Eng."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib262","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3109\/10611860008997918","article-title":"Stability of the disulfide bond in an avidin-biotin linked chimeric peptide during in vivo transcytosis through brain endothelial cells","volume":"8","author":"Kang","year":"2000","journal-title":"J. Drug Target."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib263","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1023\/A:1011981927620","article-title":"Combined use of carboxyl-directed protein pegylation and vector-mediated blood-brain barrier drug delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administration","volume":"15","author":"Pardridge","year":"1998","journal-title":"Pharmaceut. Res."},{"issue":"22","key":"10.1016\/j.biomaterials.2020.120461_bib264","doi-asserted-by":"crossref","first-page":"10227","DOI":"10.1073\/pnas.92.22.10227","article-title":"Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40\/vector complex","volume":"92","author":"Saito","year":"1995","journal-title":"Proc. Natl. Acad. Sci-Biol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib265","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1021\/mp900235k","article-title":"Pharmacokinetics and brain uptake of a genetically engineered bifunctional fusion antibody targeting the mouse transferrin receptor","volume":"7","author":"Boado","year":"2010","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib266","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1124\/dmd.111.042903","article-title":"Brain-penetrating IgG-iduronate 2-sulfatase fusion protein for the mouse","volume":"40","author":"Zhou","year":"2012","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib267","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1021\/mp1003515","article-title":"Receptor-mediated abeta amyloid antibody targeting to Alzheimer's disease mouse brain","volume":"8","author":"Zhou","year":"2011","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib268","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1124\/dmd.110.036012","article-title":"Brain-penetrating tumor necrosis factor decoy receptor in the mouse","volume":"39","author":"Zhou","year":"2011","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib269","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1124\/dmd.109.031534","article-title":"Monoclonal antibody-glial-derived neurotrophic factor fusion protein penetrates the blood-brain barrier in the mouse","volume":"38","author":"Zhou","year":"2010","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib270","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1021\/mp200136x","article-title":"Reversal of lysosomal storage in brain of adult MPS-I mice with intravenous trojan horse-iduronidase fusion protein","volume":"8","author":"Boado","year":"2011","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib271","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1021\/acs.molpharmaceut.7b00937","article-title":"Enhanced delivery of galanin conjugates to the brain through bioengineering of the anti-transferrin receptor antibody OX26","volume":"15","author":"Thom","year":"2018","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib272","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1021\/mp1001763","article-title":"Re-engineering erythropoietin as an IgG fusion protein that penetrates the blood-brain barrier in the mouse","volume":"7","author":"Zhou","year":"2010","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib273","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1124\/dmd.110.036012","article-title":"Brain-penetrating tumor necrosis factor decoy receptor in the mouse","volume":"39","author":"Zhou","year":"2011","journal-title":"Drug Metab. Dispos."},{"issue":"10","key":"10.1016\/j.biomaterials.2020.120461_bib274","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1038\/jcbfm.2012.97","article-title":"Brain protection from stroke with intravenous TNF alpha decoy receptor-Trojan horse fusion protein","volume":"32","author":"Sumbria","year":"2012","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"9","key":"10.1016\/j.biomaterials.2020.120461_bib275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108024","article-title":"Etanercept attenuates myocardial ischemia\/reperfusion injury by decreasing inflammation and oxidative stress","volume":"9","author":"Yang","year":"2014","journal-title":"PloS One"},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2020.120461_bib276","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jbiotec.2010.01.011","article-title":"Selective targeting of a TNFR decoy receptor pharmaceutical to the primate brain as a receptor-specific IgG fusion protein","volume":"146","author":"Boado","year":"2010","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.biomaterials.2020.120461_bib277","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.brainres.2013.02.022","article-title":"Combination stroke therapy in the mouse with blood-brain barrier penetrating IgG-GDNF and IgG-TNF decoy receptor fusion proteins","volume":"1507","author":"Sumbria","year":"2013","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120461_bib278","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1021\/acs.molpharmaceut.7b00200","article-title":"Blood-brain barrier penetrating biologic TNF-alpha inhibitor for Alzheimer's disease","volume":"14","author":"Chang","year":"2017","journal-title":"Mol. Pharm."},{"issue":"6571","key":"10.1016\/j.biomaterials.2020.120461_bib279","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/380252a0","article-title":"Functional recovery in parkinsonian monkeys treated with GDNF","volume":"380","author":"Gash","year":"1996","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib280","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nn1175","article-title":"Localized striatal delivery of GDNF as a treatment for Parkinson disease","volume":"7","author":"Kirik","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biomaterials.2020.120461_bib281","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.brainres.2010.06.059","article-title":"Intravenous treatment of experimental Parkinson's disease in the mouse with an IgG-GDNF fusion protein that penetrates the blood-brain barrier","volume":"1352","author":"Fu","year":"2010","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib282","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.ymthe.2018.02.032","article-title":"A blood-brain-barrier-penetrating anti-human transferrin receptor antibody fusion protein for neuronopathic mucopolysaccharidosis II","volume":"26","author":"Sonoda","year":"2018","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib283","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1021\/mp200136x","article-title":"Reversal of lysosomal storage in brain of adult MPS-I mice with intravenous Trojan horse-iduronidase fusion protein","volume":"8","author":"Boado","year":"2011","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120461_bib284","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1021\/acs.molpharmaceut.7b00200","article-title":"Blood\u2013brain barrier penetrating biologic TNF-\u03b1 inhibitor for Alzheimer's disease","volume":"14","author":"Chang","year":"2017","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib285","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1021\/mp400004a","article-title":"Pharmacokinetics and brain uptake of an IgG-TNF decoy receptor fusion protein following intravenous, intraperitoneal, and subcutaneous administration in mice","volume":"10","author":"Sumbria","year":"2013","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib286","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1124\/jpet.111.185876","article-title":"Neuroprotection with a brain-penetrating biologic tumor necrosis factor inhibitor","volume":"339","author":"Zhou","year":"2011","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.biomaterials.2020.120461_bib287","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.brainres.2010.06.059","article-title":"Intravenous treatment of experimental Parkinson's disease in the mouse with an IgG-GDNF fusion protein that penetrates the blood\u2013brain barrier","volume":"1352","author":"Fu","year":"2010","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120461_bib288","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1124\/dmd.111.038349","article-title":"Chronic dosing of mice with a transferrin receptor monoclonal antibody-glial-derived neurotrophic factor fusion protein","volume":"39","author":"Zhou","year":"2011","journal-title":"Drug Metab. Dispos."},{"issue":"11","key":"10.1016\/j.biomaterials.2020.120461_bib289","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1021\/acs.molpharmaceut.8b00594","article-title":"Brain penetrating bifunctional erythropoietin-transferrin receptor antibody fusion protein for Alzheimer's disease","volume":"15","author":"Chang","year":"2018","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib290","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1021\/acs.molpharmaceut.7b00958","article-title":"Reduction in brain heparan sulfate with systemic administration of an IgG trojan horse-sulfamidase fusion protein in the mucopolysaccharidosis type IIIA mouse","volume":"15","author":"Boado","year":"2018","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib291","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/j.pain.0000000000000810","article-title":"Enhanced delivery of IL-1 receptor antagonist to the central nervous system as a novel anti-transferrin receptor-IL-1RA fusion reverses neuropathic mechanical hypersensitivity","volume":"158","author":"Webster","year":"2017","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib292","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymthe.2018.12.005","article-title":"Iduronate-2-Sulfatase with anti-human transferrin receptor antibody for neuropathic mucopolysaccharidosis II: a phase 1\/2 trial","volume":"27","author":"Okuyama","year":"2019","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib293","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1023\/A:1007592720793","article-title":"Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor","volume":"17","author":"Coloma","year":"2000","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib294","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/bit.21120","article-title":"Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier","volume":"96","author":"Boado","year":"2007","journal-title":"Biotechnol. Bioeng."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib295","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/bit.21602","article-title":"Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier","volume":"99","author":"Boado","year":"2008","journal-title":"Biotechnol. Bioeng."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib296","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/bit.21764","article-title":"GDNF fusion protein for targeted-drug delivery across the human blood-brain barrier","volume":"100","author":"Boado","year":"2008","journal-title":"Biotechnol. Bioeng."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib297","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1021\/mp900103n","article-title":"Tumor necrosis factor receptor-IgG fusion protein for targeted drug delivery across the human blood-brain barrier","volume":"6","author":"Hui","year":"2009","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib298","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1021\/bc900382q","article-title":"Genetic engineering of a bifunctional IgG fusion protein with iduronate-2-sulfatase","volume":"21","author":"Lu","year":"2010","journal-title":"Bioconjugate Chem."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib299","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/10611860903353362","article-title":"Genetic engineering of IgG-glucuronidase fusion proteins","volume":"18","author":"Boado","year":"2010","journal-title":"J. Drug Target."},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120461_bib300","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/bit.23118","article-title":"Expression in CHO cells and pharmacokinetics and brain uptake in the Rhesus monkey of an IgG-iduronate-2-sulfatase fusion protein","volume":"108","author":"Lu","year":"2011","journal-title":"Biotechnol. Bioeng."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib301","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/bit.24795","article-title":"Pharmacokinetics and brain uptake in the rhesus monkey of a fusion protein of arylsulfatase a and a monoclonal antibody against the human insulin receptor","volume":"110","author":"Boado","year":"2013","journal-title":"Biotechnol. Bioeng."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib302","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1021\/bc060349x","article-title":"Fusion antibody for Alzheimer's disease with bidirectional transport across the blood-brain barrier and abeta fibril disaggregation","volume":"18","author":"Boado","year":"2007","journal-title":"Bioconjugate Chem."},{"issue":"10","key":"10.1016\/j.biomaterials.2020.120461_bib303","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1124\/dmd.112.046375","article-title":"Glycemic control and chronic dosing of rhesus monkeys with a fusion protein of iduronidase and a monoclonal antibody against the human insulin receptor","volume":"40","author":"Boado","year":"2012","journal-title":"Drug Metab. Dispos."},{"issue":"11","key":"10.1016\/j.biomaterials.2020.120461_bib304","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/bit.25289","article-title":"Insulin receptor antibody-iduronate 2-sulfatase fusion protein: pharmacokinetics, anti-drug antibody, and safety pharmacology in Rhesus monkeys","volume":"111","author":"Boado","year":"2014","journal-title":"Biotechnol. Bioeng."},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120461_bib305","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1021\/mp500258p","article-title":"Insulin receptor antibody-sulfamidase fusion protein penetrates the primate blood-brain barrier and reduces glycosoaminoglycans in Sanfilippo type A cells","volume":"11","author":"Boado","year":"2014","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib306","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jbiotec.2009.08.019","article-title":"AGT-181: expression in CHO cells and pharmacokinetics, safety, and plasma iduronidase enzyme activity in Rhesus monkeys","volume":"144","author":"Boado","year":"2009","journal-title":"J. Biotechnol."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib307","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1021\/acs.molpharmaceut.6b01166","article-title":"Brain and organ uptake in the rhesus monkey in vivo of recombinant iduronidase compared to an insulin receptor antibody-iduronidase fusion protein","volume":"14","author":"Boado","year":"2017","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib308","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40259-018-0264-7","article-title":"Plasma pharmacokinetics of valanafusp alpha, a human insulin receptor antibody-iduronidase fusion protein, in patients with mucopolysaccharidosis type I","volume":"32","author":"Pardridge","year":"2018","journal-title":"BioDrugs"},{"issue":"120","key":"10.1016\/j.biomaterials.2020.120461_bib309","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.ymgme.2016.11.121","article-title":"Intravenous infusion of iduronidase-IgG and its impact on the central nervous system in children with Hurler syndrome","volume":"1","author":"Giugliani","year":"2017","journal-title":"Mol. Genet. Metabol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib310","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13023-018-0849-8","article-title":"Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial","volume":"13","author":"Giugliani","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib311","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1021\/bc3005123","article-title":"IgG-enzyme fusion protein: pharmacokinetics and anti-drug antibody response in rhesus monkeys","volume":"24","author":"Boado","year":"2013","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.biomaterials.2020.120461_bib312","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1146\/annurev-pharmtox-010814-124852","article-title":"Targeting receptor-mediated transport for delivery of biologics across the blood-brain barrier","volume":"55","author":"Lajoie","year":"2015","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib313","doi-asserted-by":"crossref","first-page":"308","DOI":"10.7150\/thno.17155","article-title":"Bivalent brain shuttle increases antibody uptake by monovalent binding to the transferrin receptor","volume":"7","author":"Hultqvist","year":"2017","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.biomaterials.2020.120461_bib314","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib315","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2015.11.024","article-title":"Discovery of novel blood-brain barrier targets to enhance brain uptake of therapeutic antibodies","volume":"89","author":"Zuchero","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.biomaterials.2020.120461_bib316","first-page":"703545","article-title":"Receptor-mediated endocytosis and brain delivery of therapeutic biologics","author":"Xiao","year":"2013","journal-title":"Int. J Cell Biol."},{"issue":"31","key":"10.1016\/j.biomaterials.2020.120461_bib317","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.2174\/0929867322666150716114625","article-title":"Lipoprotein-related and apolipoprotein-mediated delivery systems for drug targeting and imaging","volume":"22","author":"Almer","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biomaterials.2020.120461_bib318","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101665","article-title":"Targeting the transferrin receptor for brain drug delivery","volume":"181","author":"Johnsen","year":"2019","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib319","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016575","article-title":"Peripheral delivery of a CNS targeted, metalo-protease reduces abeta toxicity in a mouse model of Alzheimer's disease","volume":"6","author":"Spencer","year":"2011","journal-title":"PloS One"},{"issue":"18","key":"10.1016\/j.biomaterials.2020.120461_bib320","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1073\/pnas.0702170104","article-title":"Targeted delivery of proteins across the blood-brain barrier","volume":"104","author":"Spencer","year":"2007","journal-title":"Proc. Natl. Acad. Sci-Biol."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib321","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1046\/j.1471-4159.2002.01201.x","article-title":"High transcytosis of melanotransferrin (P97) across the blood-brain barrier","volume":"83","author":"Demeule","year":"2002","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.biomaterials.2020.120461_bib322","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1177\/0271678X18772998","article-title":"A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical model","volume":"39","author":"Thom","year":"2019","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"9","key":"10.1016\/j.biomaterials.2020.120461_bib323","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1523\/JNEUROSCI.4785-13.2014","article-title":"Comparison of five peptide vectors for improved brain delivery of the lysosomal enzyme arylsulfatase A","volume":"34","author":"Bockenhoff","year":"2014","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib324","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1124\/jpet.301.2.605","article-title":"Enhanced neuroprotective effects of basic fibroblast growth factor in regional brain ischemia after conjugation to a blood-brain barrier delivery vector","volume":"301","author":"Song","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib325","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1023\/A:1018940732550","article-title":"Transport of human recombinant brain-derived neurotrophic factor (bdnf) through the rat blood-brain-barrier in-vivo using vector-mediated peptide drug-delivery","volume":"11","author":"Pardridge","year":"1994","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/j.biomaterials.2020.120461_bib326","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.brainres.2006.07.005","article-title":"Blood-brain barrier targeting of BDNF improves motor function in rats with middle cerebral artery occlusion","volume":"1111","author":"Zhang","year":"2006","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib327","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1021\/bc9800522","article-title":"Retention of biologic activity of human epidermal growth factor following conjugation to a blood-brain barrier drug delivery vector via an extended poly(ethylene glycol) linker","volume":"10","author":"Deguchi","year":"1999","journal-title":"Bioconjugate Chem."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib328","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/10611860290022679","article-title":"Pharmacokinetics and brain uptake of biotinylated basic fibroblast growth factor conjugated to a blood-brain barrier drug delivery system","volume":"10","author":"Wu","year":"2002","journal-title":"J. Drug Target."},{"issue":"9","key":"10.1016\/j.biomaterials.2020.120461_bib329","first-page":"937","article-title":"Pharmacokinetics and blood-brain barrier transport of an anti-transferrin receptor monoclonal antibody (OX26) in rats after chronic treatment with the antibody","volume":"26","author":"Wu","year":"1998","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib330","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0090-9556(25)08314-X","article-title":"Pharmacokinetics and saturable blood-brain-barrier transport of biotin bound to a conjugate of avidin and a monoclonal-antibody to the transferrin receptor","volume":"22","author":"Kang","year":"1994","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib331","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0022-3565(25)38699-4","article-title":"Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin monoclonal-antibody conjugate","volume":"269","author":"Kang","year":"1994","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120461_bib332","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1073\/pnas.90.7.2618","article-title":"Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery","volume":"90","author":"Bickel","year":"1993","journal-title":"Proc. Natl. Acad. Sci-Biol."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2020.120461_bib333","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0006-8993(00)03108-5","article-title":"Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin","volume":"889","author":"Zhang","year":"2001","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib334","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1161\/01.STR.32.6.1378","article-title":"Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brain-derived neurotrophic factor conjugated to a blood-brain barrier drug targeting system","volume":"32","author":"Zhang","year":"2001","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib335","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1073\/pnas.96.1.254","article-title":"Neuroprotection with noninvasive neurotrophin delivery to the brain","volume":"96","author":"Wu","year":"1999","journal-title":"Proc. Natl. Acad. Sci-Biol."},{"issue":"9\u201310","key":"10.1016\/j.biomaterials.2020.120461_bib336","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1097\/00001756-199707070-00039","article-title":"A non-invasive transport system for GDNF across the blood-brain barrier","volume":"8","author":"Albeck","year":"1997","journal-title":"Neuroreport"},{"issue":"5093","key":"10.1016\/j.biomaterials.2020.120461_bib337","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.8420006","article-title":"Blood-brain barrier penetration and in vivo activity of an NGF conjugate","volume":"259","author":"Friden","year":"1993","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib338","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-4886(95)90037-3","article-title":"Effects of transferrin receptor antibody-NGF conjugate on young and aged septal transplants in oculo","volume":"132","author":"Backman","year":"1995","journal-title":"Exp. Neurol."},{"issue":"17","key":"10.1016\/j.biomaterials.2020.120461_bib339","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1523\/JNEUROSCI.16-17-05437.1996","article-title":"Systemic administration of a nerve growth factor conjugate reverses age-related cognitive dysfunction and prevents cholinergic neuron atrophy","volume":"16","author":"Backman","year":"1996","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib340","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0022-3565(25)38495-8","article-title":"NGF and anti-transferrin receptor antibody conjugate: short and long-term effects on survival of cholinergic neurons in intraocular septal transplants","volume":"268","author":"Granholm","year":"1994","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib341","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0006-8993(96)00398-8","article-title":"Atrophy of cholinergic basal forebrain neurons following excitotoxic cortical lesions is reversed by intravenous administration of an NGF conjugate","volume":"728","author":"Charles","year":"1996","journal-title":"Brain Res."},{"issue":"19","key":"10.1016\/j.biomaterials.2020.120461_bib342","doi-asserted-by":"crossref","first-page":"9077","DOI":"10.1073\/pnas.91.19.9077","article-title":"Intravenous administration of a transferrin receptor antibody nerve growth-factor conjugate prevents the degeneration of cholinergic striatal neurons in a model of Huntington disease","volume":"91","author":"Kordower","year":"1994","journal-title":"Proc. Natl. Acad. Sci-Biol."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib343","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1124\/jpet.104.082974","article-title":"Delivery of beta-galactosidase to mouse brain via the blood-brain barrier transferrin receptor","volume":"313","author":"Zhang","year":"2005","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib344","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/exnr.1996.0178","article-title":"Transcytosis of protein through the mammalian cerebral epithelium and endothelium .3. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor","volume":"142","author":"Broadwell","year":"1996","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biomaterials.2020.120461_bib345","series-title":"Poster presented at AACR Annual Meeting April","article-title":"ANG-4043: a new brain penetrant peptide-mAb conjugate that reduces tumor growth in a HER2-positive orthotopic tumor model","author":"Lachowicz","year":"2013"},{"key":"10.1016\/j.biomaterials.2020.120461_bib346","series-title":"Society of neuro-oncology SNO Annual Meeting November","article-title":"Design of new Angiopep-2-anti-EGFR and Angiopep-2-anti-HER2 derivatives with increased blood-brain barrier permeability for treatment of brain tumors","author":"Lachowicz","year":"2012"},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib347","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1177\/1756283X16648869","article-title":"The role of naloxegol in the management of opioid-induced bowel dysfunction","volume":"9","author":"Leppert","year":"2016","journal-title":"Ther. Adv. Gastroenter."},{"issue":"1\u20133","key":"10.1016\/j.biomaterials.2020.120461_bib348","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2007.02.061","article-title":"Neuroprotective effects of the novel polyethylene glycol-hemoglobin conjugate SB1 on experimental cerebral thromboembolism in rats","volume":"566","author":"Ji","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib349","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0169-409X(02)00029-7","article-title":"Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation","volume":"54","author":"Veronese","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.biomaterials.2020.120461_bib350","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/sj.ijo.0802431","article-title":"Effect of dietary restraint during and following pegylated recombinant leptin (PEG-OB) treatment of overweight men","volume":"27","author":"Lejeune","year":"2003","journal-title":"Int. J. Obes."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib351","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.ijo.0801952","article-title":"The effect of pegylated recombinant human leptin (PEG-OB) on weight loss and inflammatory status in obese subjects","volume":"26","author":"Hukshorn","year":"2002","journal-title":"Int. J. Obes."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib352","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/protein\/gzh102","article-title":"Engineering a pharmacologically superior form of leptin for the treatment of obesity","volume":"18","author":"Lo","year":"2005","journal-title":"Protein Eng. Des. Sel."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib353","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1161\/01.STR.22.5.655","article-title":"Polyethylene glycol-conjugated superoxide dismutase fails to augment brain superoxide dismutase activity in piglets","volume":"22","author":"Haun","year":"1991","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib354","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF00688633","article-title":"The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion","volume":"68","author":"Kuroiwa","year":"1985","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib355","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/01.STR.23.6.865","article-title":"Brain and tissue distribution of polyethylene-glycol conjugated superoxide-dismutase in rats","volume":"23","author":"Yoshida","year":"1992","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.biomaterials.2020.120461_bib356","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1039\/C4PY00039K","article-title":"Pluronic (R) block-copolymers in medicine: from chemical and biological versatility to rationalisation and clinical advances","volume":"5","author":"Pitto-Barry","year":"2014","journal-title":"Polym Chem-Uk"},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib357","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0169-409X(02)00047-9","article-title":"Pluronic((R)) block copolymers for overcoming drug resistance in cancer","volume":"54","author":"Kabanov","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120461_bib358","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1021\/mp500298q","article-title":"Pluronics and MDR reversal: an update","volume":"11","author":"Alakhova","year":"2014","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib359","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0022-3565(24)29254-5","article-title":"Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization","volume":"299","author":"Batrakova","year":"2001","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib360","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1021\/bc049730c","article-title":"Polypeptide point modifications with fatty acid and amphiphilic block copolymers for enhanced brain delivery","volume":"16","author":"Batrakova","year":"2005","journal-title":"Bioconjugate Chem."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib361","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1124\/jpet.109.158147","article-title":"Transport across the blood-brain barrier of pluronic leptin","volume":"333","author":"Price","year":"2010","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.biomaterials.2020.120461_bib362","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2014.05.044","article-title":"Pluronic modified leptin with increased systemic circulation, brain uptake and efficacy for treatment of obesity","volume":"191","author":"Yi","year":"2014","journal-title":"J. Contr. Release"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib363","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.freeradbiomed.2010.04.039","article-title":"Pluronic-modified superoxide dismutase 1 attenuates angiotensin II-induced increase in intracellular superoxide in neurons","volume":"49","author":"Yi","year":"2010","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib364","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1021\/bc700443k","article-title":"Protein conjugation with amphiphilic block copolymers for enhanced cellular delivery","volume":"19","author":"Yi","year":"2008","journal-title":"Bioconjugate Chem."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib365","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.physbeh.2011.05.024","article-title":"Principles of strategic drug delivery to the brain (SDDB): development of anorectic and orexigenic analogs of leptin","volume":"105","author":"Banks","year":"2011","journal-title":"Physiol. Behav."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib366","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1021\/mp100102p","article-title":"Protein modification with amphiphilic block copoly(2-oxazoline)s as a new platform for enhanced cellular delivery","volume":"7","author":"Tong","year":"2010","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib367","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jconrel.2007.10.010","article-title":"Synthesis and characterization of poly(2-ethyl 2-oxazoline)-conjugates with proteins and drugs: suitable alternatives to PEG-conjugates?","volume":"125","author":"Mero","year":"2008","journal-title":"J. Contr. Release"},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib368","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1021\/bc200049d","article-title":"Polyoxazoline: chemistry, properties, and applications in drug delivery","volume":"22","author":"Viegas","year":"2011","journal-title":"Bioconjugate Chem."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib369","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1021\/mp300496x","article-title":"Conjugates of superoxide dismutase 1 with amphiphilic poly(2-oxazoline) block copolymers for enhanced brain delivery: synthesis, characterization and evaluation in vitro and in vivo","volume":"10","author":"Tong","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2020.120461_bib370","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jconrel.2014.06.017","article-title":"Agile delivery of protein therapeutics to CNS","volume":"190","author":"Yi","year":"2014","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib371","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1038\/s41467-019-11719-3","article-title":"Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy","volume":"10","author":"Galstyan","year":"2019","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120461_bib372","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.2217\/nnm.12.86","article-title":"Nanobiotechnology-based strategies for crossing the blood-brain barrier","volume":"7","author":"Jain","year":"2012","journal-title":"Nanomedicine"},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib373","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/17425247.2018.1471058","article-title":"Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region","volume":"15","author":"Agrawal","year":"2018","journal-title":"Expet Opin. Drug Deliv."},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120461_bib374","first-page":"915","article-title":"Biomedical applications of nanobiotechnology for drug design, delivery and diagnostics","volume":"7","author":"Khare","year":"2014","journal-title":"Res. J. Pharm. Technol."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib375","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10040269","article-title":"Blood-brain delivery methods using nanotechnology","volume":"10","author":"Teleanu","year":"2018","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.biomaterials.2020.120461_bib376","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s11095-007-9379-0","article-title":"Blood-brain barrier transport of therapeutics via receptor-mediation","volume":"24","author":"Jones","year":"2007","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/j.biomaterials.2020.120461_bib377","series-title":"The Blood Brain Barrier (BBB)","first-page":"71","article-title":"Nanoparticles as blood-brain barrier permeable CNS targeted drug delivery systems","author":"Grabrucker","year":"2013"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib378","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nantod.2014.04.008","article-title":"Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects","volume":"9","author":"Barua","year":"2014","journal-title":"Nano Today"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib379","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1367-5931(98)80133-6","article-title":"Encapsulation of proteins for improved delivery","volume":"2","author":"Putney","year":"1998","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib380","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.biomaterials.2013.11.001","article-title":"Enzyme delivery using the 30Kc19 protein and human serum albumin nanoparticles","volume":"35","author":"Lee","year":"2014","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib381","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1021\/nl404360k","article-title":"Dual-porosity hollow nanoparticles for the immunoprotection and delivery of nonhuman enzymes","volume":"14","author":"Ortac","year":"2014","journal-title":"Nano Lett."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120461_bib382","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.tiv.2015.06.023","article-title":"Hazard effects of nanoparticles in central nervous system: searching for biocompatible nanomaterials for drug delivery","volume":"29","author":"Leite","year":"2015","journal-title":"Toxicol. Vitro"},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120461_bib383","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1007\/s12035-016-0133-7","article-title":"Zinc oxide nanoparticle induces microglial death by NADPH-oxidase-independent reactive oxygen species as well as energy depletion","volume":"54","author":"Sharma","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"20","key":"10.1016\/j.biomaterials.2020.120461_bib384","doi-asserted-by":"crossref","first-page":"20205","DOI":"10.1007\/s11356-016-7234-8","article-title":"The effect of titanium dioxide nanoparticles on neuroinflammation response in rat brain","volume":"23","author":"Grissa","year":"2016","journal-title":"Environ. Sci. Pollut. Res. Int."},{"issue":"17","key":"10.1016\/j.biomaterials.2020.120461_bib385","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.2174\/0929867311320170006","article-title":"Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier","volume":"20","author":"Tosi","year":"2013","journal-title":"Curr. Med. Chem."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120461_bib386","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.addr.2011.12.006","article-title":"Polymeric nanoparticles for drug delivery to the central nervous system","volume":"64","author":"Patel","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib387","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1096\/fj.08-116947","article-title":"Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury","volume":"23","author":"Reddy","year":"2009","journal-title":"Faseb. J."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib388","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/STROKEAHA.111.637090","article-title":"Nanoerythropoietin is 10-times more effective than regular erythropoietin in neuroprotection in a neonatal rat model of hypoxia and ischemia","volume":"43","author":"Chen","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.biomaterials.2020.120461_bib389","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jconrel.2013.11.023","article-title":"Insight on the fate of CNS-targeted nanoparticles. Part I: rab5-dependent cell-specific uptake and distribution","volume":"174","author":"Vilella","year":"2014","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib390","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2217\/nnm.11.11","article-title":"Investigation on the mechanisms for Blood\u2013Brain Barrier crossing of brain-targeted glycopeptides nanoparticles","volume":"6","author":"Tosi","year":"2011","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib391","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2005.07.013","article-title":"Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier","volume":"108","author":"Costantino","year":"2005","journal-title":"J. Contr. Release"},{"issue":"9","key":"10.1016\/j.biomaterials.2020.120461_bib392","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.2217\/nnm.12.172","article-title":"Brain-targeted polymeric nanoparticles: in vivo evidence of different routes of administration in rodents","volume":"8","author":"Tosi","year":"2013","journal-title":"Nanomedicine"},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib393","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156452","article-title":"Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders","volume":"11","author":"Salvalaio","year":"2016","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib394","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejpb.2009.09.003","article-title":"Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters","volume":"74","author":"Gelperina","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biomaterials.2020.120461_bib395","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2147\/IJN.S54750","article-title":"Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood-brain barrier","volume":"9","author":"Chaturvedi","year":"2014","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib396","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1166\/jnn.2003.077","article-title":"Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain","volume":"4","author":"Kreuter","year":"2004","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib397","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/02652048.2012.692491","article-title":"Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB)","volume":"30","author":"Kreuter","year":"2013","journal-title":"J. Microencapsul."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib398","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1517\/17425247.2015.961420","article-title":"Long-term delivery of protein therapeutics","volume":"12","author":"Vaishya","year":"2015","journal-title":"Expet Opin. Drug Deliv."},{"issue":"10","key":"10.1016\/j.biomaterials.2020.120461_bib399","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1023\/A:1026498209874","article-title":"Protein instability in poly(lactic-co-glycolic acid) microparticles","volume":"17","author":"van de Weert","year":"2000","journal-title":"Pharmaceut. Res."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120461_bib400","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1021\/acs.bioconjchem.8b00206","article-title":"Cross-linked enzyme aggregates as versatile tool for enzyme delivery: application to polymeric nanoparticles","volume":"29","author":"Galliani","year":"2018","journal-title":"Bioconjugate Chem."},{"issue":"11","key":"10.1016\/j.biomaterials.2020.120461_bib401","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1074\/jbc.M805956200","article-title":"Functional protein delivery into neurons using polymeric nanoparticles","volume":"284","author":"Hasadsri","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120461_bib402","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/10611860903112842","article-title":"Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles","volume":"17","author":"Kurakhmaeva","year":"2009","journal-title":"J. Drug Target."},{"issue":"16","key":"10.1016\/j.biomaterials.2020.120461_bib403","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/23\/16\/165101","article-title":"Delivery of large molecules via poly(butyl cyanoacrylate) nanoparticles into the injured rat brain","volume":"23","author":"Lin","year":"2012","journal-title":"Nanotechnology"},{"issue":"12","key":"10.1016\/j.biomaterials.2020.120461_bib404","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1023\/A:1018947208597","article-title":"Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity","volume":"16","author":"Olivier","year":"1999","journal-title":"Pharmaceut. Res."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib405","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/10611860290031877","article-title":"Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier","volume":"10","author":"Kreuter","year":"2002","journal-title":"J. Drug Target."},{"issue":"10","key":"10.1016\/j.biomaterials.2020.120461_bib406","first-page":"570","article-title":"FDA approves patisiran to treat hereditary transthyretin amyloidosis","volume":"14","author":"Wood","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120461_bib407","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib408","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1183\/09031936.00022410","article-title":"Polyacrylate nanoparticles: toxicity or new nanomedicine?","volume":"36","author":"Ren","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.biomaterials.2020.120461_bib409","doi-asserted-by":"crossref","first-page":"11990","DOI":"10.1038\/srep11990","article-title":"LRP-1-mediated intracellular antibody delivery to the Central Nervous System","volume":"5","author":"Tian","year":"2015","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib410","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11596-018-1896-z","article-title":"Recombinant tissue plasminogen activator-conjugated nanoparticles effectively targets thrombolysis in a rat model of middle cerebral artery occlusion","volume":"38","author":"Deng","year":"2018","journal-title":"Curr. Med. Sci."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib411","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1039\/C0JM01350A","article-title":"Carbon nanospheres: synthesis, physicochemical properties and applications","volume":"21","author":"Nieto-Marquez","year":"2011","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.biomaterials.2020.120461_bib412","first-page":"2039","article-title":"Carbon nanospheres mediated delivery of nuclear matrix protein SMAR1 to direct experimental autoimmune encephalomyelitis in mice","volume":"11","author":"Chemmannur","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2020.120461_bib413","doi-asserted-by":"crossref","first-page":"33779","DOI":"10.1038\/srep33779","article-title":"SMAR1 binds to T(C\/G) repeat and inhibits tumor progression by regulating miR-371-373 cluster","volume":"6","author":"Mathai","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib414","first-page":"1","article-title":"Gene regulation by SMAR1: role in cellular homeostasis and cancer","volume":"1815","author":"Malonia","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biomaterials.2020.120461_bib415","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jconrel.2017.05.019","article-title":"Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease","volume":"260","author":"Agrawal","year":"2017","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2020.120461_bib416","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2147\/IJN.S30721","article-title":"Liposomes and nanotechnology in drug development: focus on neurological targets","volume":"8","author":"Ramos-Cabrer","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2020.120461_bib417","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.2147\/IJN.S147650","article-title":"Development of coated liposomes loaded with ghrelin for nose-to-brain delivery for the treatment of cachexia","volume":"12","author":"Salade","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib418","first-page":"381","article-title":"Application of liposomes in medicine and drug delivery, Artif. Cells Nanomed","volume":"44","author":"Daraee","year":"2016","journal-title":"Biotechnol."},{"issue":"10","key":"10.1016\/j.biomaterials.2020.120461_bib419","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.2042-7158.1980.tb13051.x","article-title":"Passage through the blood-brain-barrier of thyrotropin-releasing-hormone encapsulated in liposomes","volume":"32","author":"Postmes","year":"1980","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1620\/tjem.140.1","article-title":"Microautoradiographic study on the tissue localization of liposome entrapped or unentrapped H-3-Labeled beta-galactosidase injected into rats","volume":"140","author":"Onodera","year":"1983","journal-title":"Tohoku J. Exp. Med."},{"issue":"9","key":"10.1016\/j.biomaterials.2020.120461_bib421","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1161\/01.STR.21.9.1312","article-title":"Liposome-entrapped superoxide-dismutase reduces cerebral infarction in cerebral-ischemia in rats","volume":"21","author":"Imaizumi","year":"1990","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib422","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ana.410210604","article-title":"Protective effects of liposome-entrapped superoxide-dismutase on posttraumatic brain edema","volume":"21","author":"Chan","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biomaterials.2020.120461_bib423","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2016.02.026","article-title":"Nanocarriers for the treatment of glioblastoma multiforme: current state-of-the-art","volume":"227","author":"Karim","year":"2016","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib424","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2011.05.008","article-title":"TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes","volume":"154","author":"Guo","year":"2011","journal-title":"J. Contr. Release"},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2020.120461_bib425","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2005.03.005","article-title":"Transport of nerve growth factor encapsulated into liposomes across the blood-brain barrier: in vitro and in vivo studies","volume":"105","author":"Xie","year":"2005","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2020.120461_bib426","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jconrel.2015.02.012","article-title":"Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease","volume":"203","author":"Rotman","year":"2015","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib427","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11060-014-1584-1","article-title":"Cationic surface charge enhances early regional deposition of liposomes after intracarotid injection","volume":"120","author":"Joshi","year":"2014","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.biomaterials.2020.120461_bib428","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2147\/IJN.S68861","article-title":"Liposomes as nanomedical devices","volume":"10","author":"Bozzuto","year":"2015","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib429","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.nano.2014.08.004","article-title":"In vivo toxicity of cationic micelles and liposomes","volume":"11","author":"Knudsen","year":"2015","journal-title":"Nanomedicine"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib430","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/jcbfm.2012.209","article-title":"Nanoparticles for targeted delivery of antioxidant enzymes to the brain after cerebral ischemia and reperfusion injury","volume":"33","author":"Yun","year":"2013","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib431","doi-asserted-by":"crossref","DOI":"10.3390\/jfb9010011","article-title":"Formulation of poloxamers for drug delivery","volume":"9","author":"Bodratti","year":"2018","journal-title":"J. Funct. Biomater."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib432","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1038\/s41598-017-03123-y","article-title":"Pluronic F127 and D-alpha-tocopheryl polyethylene glycol succinate (TPGS) mixed micelles for targeting drug delivery across the blood brain barrier","volume":"7","author":"Meng","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib433","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.biomaterials.2012.09.047","article-title":"Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier","volume":"34","author":"Kim","year":"2013","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib434","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejpb.2006.06.003","article-title":"Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs","volume":"64","author":"Sezgin","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib435","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1021\/bc034149m","article-title":"Preparation of bionanoreactor based on core-shell structured polyion complex micelles entrapping trypsin in the core cross-linked with glutaraldehyde","volume":"15","author":"Jaturanpinyo","year":"2004","journal-title":"Bioconjugate Chem."},{"issue":"5398","key":"10.1016\/j.biomaterials.2020.120461_bib436","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1126\/science.283.5398.65","article-title":"Chain length recognition: core-shell supramolecular assembly from oppositely charged block copolymers","volume":"283","author":"Harada","year":"1999","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib437","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1021\/bc700184b","article-title":"A macrophage-nanozyme delivery system for Parkinson's disease","volume":"18","author":"Batrakova","year":"2007","journal-title":"Bioconjugate Chem."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib438","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.nano.2011.05.010","article-title":"Cross-linked antioxidant nanozymes for improved delivery to CNS","volume":"8","author":"Klyachko","year":"2012","journal-title":"Nanomedicine"},{"issue":"1\u20133","key":"10.1016\/j.biomaterials.2020.120461_bib439","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0168-3659(01)00264-4","article-title":"Pronounced activity of enzymes through the incorporation into the core of polyion complex micelles made from charged block copolymers","volume":"72","author":"Harada","year":"2001","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib440","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jconrel.2012.07.044","article-title":"Well-defined cross-linked antioxidant nanozymes for treatment of ischemic brain injury","volume":"162","author":"Manickam","year":"2012","journal-title":"J. Contr. Release"},{"issue":"1\u20133","key":"10.1016\/j.biomaterials.2020.120461_bib441","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.cbi.2010.01.005","article-title":"Visualization of exogenous delivery of nanoformulated butyrylcholinesterase to the central nervous system","volume":"187","author":"Gaydess","year":"2010","journal-title":"Chem. Biol. Interact."},{"issue":"24","key":"10.1016\/j.biomaterials.2020.120461_bib442","doi-asserted-by":"crossref","first-page":"20326","DOI":"10.1021\/acsami.8b04613","article-title":"Brain targeting delivery facilitated by ligand-functionalized layered double hydroxide nanoparticles","volume":"10","author":"Chen","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib443","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2217\/nnm.11.86","article-title":"Layered double hydroxide nanoparticles as target-specific delivery carriers: uptake mechanism and toxicity","volume":"6","author":"Choi","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biomaterials.2020.120461_bib444","first-page":"5159","article-title":"Bioconjugation of recombinant tissue plasminogen activator to magnetic nanocarriers for targeted thrombolysis","volume":"7","author":"Yang","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib445","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bbrc.2019.06.079","article-title":"Polyacrylic acid-coated nanoparticles loaded with recombinant tissue plasminogen activator for the treatment of mice with ischemic stroke","volume":"516","author":"Huang","year":"2019","journal-title":"Biochem Bioph Res Co"},{"issue":"10","key":"10.1016\/j.biomaterials.2020.120461_bib446","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.4155\/tde.15.56","article-title":"Targeted drug delivery to the brain using magnetic nanoparticles","volume":"6","author":"Thomsen","year":"2015","journal-title":"Ther. Deliv."},{"issue":"19","key":"10.1016\/j.biomaterials.2020.120461_bib447","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1016\/j.biomaterials.2009.02.034","article-title":"Magnetically targeted thrombolysis with recombinant tissue plasminogen activator bound to polyacrylic acid-coated nanoparticles","volume":"30","author":"Ma","year":"2009","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib448","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11481-016-9687-4","article-title":"Perspectives on dual targeting delivery systems for brain tumors","volume":"12","author":"Gao","year":"2017","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib449","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.apsb.2016.05.013","article-title":"Progress and perspectives on targeting nanoparticles for brain drug delivery","volume":"6","author":"Gao","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2020.120461_bib450","first-page":"117","article-title":"The dual role of sialic acid in the hepatic recognition and catabolism of serum glycoproteins","volume":"40","author":"Ashwell","year":"1974","journal-title":"Biochem. Soc. Symp."},{"key":"10.1016\/j.biomaterials.2020.120461_bib451","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/9780470122860.ch3","article-title":"The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins","volume":"41","author":"Ashwell","year":"1974","journal-title":"Adv. Enzymol. Relat. Area Mol. Biol."},{"key":"10.1016\/j.biomaterials.2020.120461_bib452","first-page":"41","article-title":"Structural characteristics and regulation of the asialoglycoprotein receptor","volume":"4","author":"Stockert","year":"1991","journal-title":"Targeted Diagn. Ther."},{"key":"10.1016\/j.biomaterials.2020.120461_bib453","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0076-6879(74)34090-6","article-title":"A membrane receptor protein for asialoglycoproteins","volume":"34","author":"Pricer","year":"1974","journal-title":"Methods Enzymol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib454","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0021-9258(18)99337-3","article-title":"Physical and chemical studies on ceruloplasmin. V. Metabolic studies on sialic acid-free ceruloplasmin in vivo","volume":"243","author":"Morell","year":"1968","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib455","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1432-1033.1988.tb14048.x","article-title":"Involvement of various organs in the initial plasma-clearance of differently glycosylated rat-liver secretory proteins","volume":"173","author":"Gross","year":"1988","journal-title":"Eur. J. Biochem."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib456","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0021-9258(19)76994-4","article-title":"The role of sialic acid in determining the survival of glycoproteins in the circulation","volume":"246","author":"Morell","year":"1971","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib457","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/jps.21504","article-title":"Effects of glycosylation on the stability of protein pharmaceuticals","volume":"98","author":"Sola","year":"2009","journal-title":"J. Pharmaceut. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib458","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1993.tb18347.x","article-title":"Protein glycosylation. Structural and functional aspects","volume":"218","author":"Lis","year":"1993","journal-title":"Eur. J. Biochem."},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120461_bib459","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3891\/acta.chem.scand.29b-0887","article-title":"The resistance of glycoproteins to proteolytic inactivation","volume":"29","author":"Vegarud","year":"1975","journal-title":"Acta Chem. Scand. B."},{"issue":"9","key":"10.1016\/j.biomaterials.2020.120461_bib460","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/bit.260170918","article-title":"Glycosylation of Proteins: a new method of enzyme stabilization","volume":"17","author":"Vegarud","year":"1975","journal-title":"Biotechnol. Bioeng."},{"issue":"Suppl 3","key":"10.1016\/j.biomaterials.2020.120461_bib461","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0959-8049(94)00401-3","article-title":"Glycosylation of recombinant human granulocyte colony stimulating factor: implications for stability and potency","volume":"30A","author":"Nissen","year":"1994","journal-title":"Eur. J Canc."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib462","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.biologicals.2003.12.002","article-title":"Human serum inactivates non-glycosylated but not glycosylated granulocyte colony stimulating factor by a protease dependent mechanism: significance of carbohydrates on the glycosylated molecule","volume":"32","author":"Carter","year":"2004","journal-title":"Biologicals"},{"issue":"15","key":"10.1016\/j.biomaterials.2020.120461_bib463","doi-asserted-by":"crossref","first-page":"9778","DOI":"10.1016\/S0021-9258(18)92888-7","article-title":"Glycosylation of human protein C affects its secretion, processing, functional activities, and activation by thrombin","volume":"266","author":"Grinnell","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib464","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.bbrc.2004.01.153","article-title":"Glycosylation of onconase increases its conformational stability and toxicity for cancer cells","volume":"315","author":"Kim","year":"2004","journal-title":"Biochem Bioph Res Co"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib465","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1210\/endo-112-4-1331","article-title":"Glycosylation of thyroid-stimulating hormone in pituitary tumor cells: influence of high mannose oligosaccharide units on subunit aggregation, combination, and intracellular degradation","volume":"112","author":"Weintraub","year":"1983","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib466","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/jir.1993.13.267","article-title":"Effect of carbohydrates on the pharmacokinetics of human interferon-gamma","volume":"13","author":"Sareneva","year":"1993","journal-title":"J. Interferon Res."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib467","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/bp070118k","article-title":"Fc glycans terminated with N-acetylglucosamine residues increase antibody resistance to papain","volume":"23","author":"Raju","year":"2007","journal-title":"Biotechnol. Prog."},{"issue":"10","key":"10.1016\/j.biomaterials.2020.120461_bib468","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1021\/pr070317z","article-title":"Site determination of protein glycosylation based on digestion with immobilized nonspecific proteases and Fourier transform ion cyclotron resonance mass spectrometry","volume":"6","author":"Clowers","year":"2007","journal-title":"J. Proteome Res."},{"issue":"7\u20138","key":"10.1016\/j.biomaterials.2020.120461_bib469","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.drudis.2007.02.010","article-title":"Sialic acids: carbohydrate moieties that influence the biological and physical properties of biopharmaceutical proteins and living cells","volume":"12","author":"Byrne","year":"2007","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib470","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1042\/bj1760103","article-title":"Plasma clearance of glycoproteins with terminal mannose and N-acetylglucosamine by liver non-parenchymal cells. Studies with beta-glucuronidase, N-acetyl-beta-D-glucosaminidase, ribonuclease B and agalacto-orosomucoid","volume":"176","author":"Schlesinger","year":"1978","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib471","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/bj1920597","article-title":"The role of extra-hepatic tissues in the receptor-mediated plasma clearance of glycoproteins terminated by mannose or N-acetylglucosamine","volume":"192","author":"Schlesinger","year":"1980","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib472","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1042\/bj1940209","article-title":"Isolation and characterization of a mannose\/N-acetylglucosamine\/fucose-binding protein from rat liver","volume":"194","author":"Townsend","year":"1981","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib473","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0092-8674(78)90102-2","article-title":"Human beta-glucuronidase: in vivo clearance and in vitro uptake by a glycoprotein recognition system on reticuloendothelial cells","volume":"15","author":"Achord","year":"1978","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.biomaterials.2020.120461_bib474","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1021\/jm300418d","article-title":"Synthesis and biological evaluation of an orally active glycosylated endomorphin-1","volume":"55","author":"Varamini","year":"2012","journal-title":"J. Med. Chem."},{"issue":"15","key":"10.1016\/j.biomaterials.2020.120461_bib475","doi-asserted-by":"crossref","first-page":"7114","DOI":"10.1073\/pnas.91.15.7114","article-title":"Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier","volume":"91","author":"Polt","year":"1994","journal-title":"Proc. Natl. Acad. Sci-Biol."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib476","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1073\/pnas.89.6.2218","article-title":"Increased permeability across the blood-nerve barrier of albumin glycated in vitro and in vivo from patients with diabetic polyneuropathy","volume":"89","author":"Poduslo","year":"1992","journal-title":"Proc. Natl. Acad. Sci-Biol."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2020.120461_bib477","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0169-328X(94)90222-4","article-title":"Glycation increases the permeability of proteins across the blood nerve and blood-brain barriers","volume":"23","author":"Poduslo","year":"1994","journal-title":"Mol. Brain Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib478","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0006-291X(74)80356-6","article-title":"A recognition marker required for uptake of a lysosomal enzyme by cultured fibroblasts","volume":"57","author":"Hickman","year":"1974","journal-title":"Biochem Bioph Res Co"},{"key":"10.1016\/j.biomaterials.2020.120461_bib479","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.bi.51.070182.002531","article-title":"Carbohydrate-specific receptors of the liver","volume":"51","author":"Ashwell","year":"1982","journal-title":"Annu. Rev. Biochem."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120461_bib480","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1073\/pnas.0712147105","article-title":"Chemically modified beta-glucuronidase crosses blood-brain barrier and clears neuronal storage in murine mucopolysaccharidosis VII","volume":"105","author":"Grubb","year":"2008","journal-title":"Proc. Natl. Acad. Sci-Biol."},{"issue":"42","key":"10.1016\/j.biomaterials.2020.120461_bib481","doi-asserted-by":"crossref","first-page":"17022","DOI":"10.1073\/pnas.1214779109","article-title":"Biochemical evidence for superior correction of neuronal storage by chemically modified enzyme in murine mucopolysaccharidosis VII","volume":"109","author":"Huynh","year":"2012","journal-title":"Proc. Natl. Acad. Sci-Biol."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120461_bib482","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040509","article-title":"Systemic administration of tripeptidyl peptidase I in a mouse model of late infantile neuronal ceroid lipofuscinosis: effect of glycan modification","volume":"7","author":"Meng","year":"2012","journal-title":"PloS One"},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2020.120461_bib483","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijpharm.2005.06.007","article-title":"Improving the therapeutic efficacy of peptides and proteins: a role for polysialic acids","volume":"300","author":"Gregoriadis","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.biomaterials.2020.120461_bib484","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/labinvest.3700656","article-title":"Diversity in cell surface sialic acid presentations: implications for biology and disease","volume":"87","author":"Varki","year":"2007","journal-title":"Lab. Invest."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib485","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/jps.22054","article-title":"Delivery of therapeutic proteins","volume":"99","author":"Pisal","year":"2010","journal-title":"J. Pharmaceut. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib486","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/protein\/3.1.39","article-title":"Lipid modification of proteins and their membrane-transport","volume":"3","author":"Kabanov","year":"1989","journal-title":"Protein Eng."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib487","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1021\/bc00035a016","article-title":"Fatty-acid acylated peroxidase as a model for the study of interactions of hydrophobically-modified proteins with mammalian-cells","volume":"6","author":"Slepnev","year":"1995","journal-title":"Bioconjugate Chem."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2020.120461_bib488","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0014-5793(91)80037-4","article-title":"Fatty-acid acylated fab-fragments of antibodies to neurospecific proteins as carriers for neuroleptic targeted delivery in brain","volume":"287","author":"Chekhonin","year":"1991","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib489","first-page":"129","article-title":"Transport of hydrophobized fragments of antibodies through the blood-brain barrier","volume":"7","author":"Chekhonin","year":"1995","journal-title":"Neuroreport"},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2020.120461_bib490","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0014-5793(91)80037-4","article-title":"Fatty acid acylated Fab-fragments of antibodies to neurospecific proteins as carriers for neuroleptic targeted delivery in brain","volume":"287","author":"Chekhonin","year":"1991","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biomaterials.2020.120461_bib491","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/B978-0-12-391860-4.00012-4","article-title":"Lipid nanoparticles for drug targeting to the brain","volume":"508","author":"Bondi","year":"2012","journal-title":"Methods Enzymol."},{"issue":"2\u20133","key":"10.1016\/j.biomaterials.2020.120461_bib492","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1385\/JMN:16:2-3:181","article-title":"Essential polyunsaturated fatty acids and the barrier to the brain: the components of a model for transport","volume":"16","author":"Edmond","year":"2001","journal-title":"J. Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib493","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1046\/j.1471-4159.1998.70031227.x","article-title":"Fatty acid transport and utilization for the developing brain","volume":"70","author":"Edmond","year":"1998","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120461_bib494","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1021\/bc800045x","article-title":"Covalent modifications of antitetanus F(ab')2 fragments with natural and synthetic polyamines and their effects on the antibody endocytosis in cultured HL60 cells","volume":"19","author":"Herve","year":"2008","journal-title":"Bioconjugate Chem."},{"issue":"20","key":"10.1016\/j.biomaterials.2020.120461_bib495","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1021\/bi0359574","article-title":"Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques","volume":"43","author":"Poduslo","year":"2004","journal-title":"Biochemistry-Us"},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2020.120461_bib496","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jim.2005.09.015","article-title":"Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies","volume":"307","author":"Welfringer","year":"2005","journal-title":"J. Immunol. Methods"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib497","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1046\/j.1471-4159.1996.67020734.x","article-title":"Increased permeability of superoxide dismutase at the blood-nerve and blood-brain barriers with retained enzymatic activity after covalent modification with the naturally occurring polyamine, putrescine","volume":"67","author":"Poduslo","year":"1996","journal-title":"J. Neurochem."},{"issue":"31","key":"10.1016\/j.biomaterials.2020.120461_bib498","doi-asserted-by":"crossref","first-page":"15214","DOI":"10.1016\/S0021-9258(18)48160-4","article-title":"Absorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries - model system of blood-brain-barrier transport","volume":"262","author":"Kumagai","year":"1987","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.biomaterials.2020.120461_bib499","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1073\/pnas.86.12.4761","article-title":"Blood-brain-barrier transport of cationized immunoglobulin-G - enhanced delivery compared to native protein","volume":"86","author":"Triguero","year":"1989","journal-title":"Proc. Natl. Acad. Sci-Biol."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib500","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1471-4159.2007.04591.x","article-title":"In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques","volume":"102","author":"Poduslo","year":"2007","journal-title":"J. Neurochem."},{"issue":"15","key":"10.1016\/j.biomaterials.2020.120461_bib501","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1097\/00001756-200110290-00011","article-title":"Amyloid beta peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood-brain barrier","volume":"12","author":"Poduslo","year":"2001","journal-title":"Neuroreport"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib502","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1046\/j.1471-4159.1998.71041651.x","article-title":"Putrescine-modified nerve growth factor: bioactivity, plasma pharmacokinetics, blood-brain\/nerve barrier permeability, and nervous system biodistribution","volume":"71","author":"Poduslo","year":"1998","journal-title":"J. Neurochem."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2020.120461_bib503","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0006-8993(97)00041-3","article-title":"Postischemic, systemic administration of polyamine-modified superoxide dismutase reduces hippocampal CA1 neurodegeneration in rat global cerebral ischemia","volume":"754","author":"Wengenack","year":"1997","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib504","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/exnr.1999.7142","article-title":"Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis","volume":"159","author":"Reinholz","year":"1999","journal-title":"Exp. Neurol."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib505","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/1531-8249(200012)48:6<943::AID-ANA18>3.0.CO;2-1","article-title":"Therapeutic benefit of polyamine-modified catalase as a scavenger of hydrogen peroxide and nitric oxide in familial amyotrophic lateral sclerosis transgenics","volume":"48","author":"Poduslo","year":"2000","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib506","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1006\/exnr.1999.7117","article-title":"Plasma pharmacokinetics, nervous system biodistribution and biostability, and spinal cord permeability at the blood-brain barrier of putrescine-modified catalase in the adult rat","volume":"159","author":"Reinholz","year":"1999","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib507","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0006-291X(87)90726-1","article-title":"Chimeric peptides as a vehicle for peptide pharmaceutical delivery through the blood-brain-barrier","volume":"146","author":"Pardridge","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib508","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj2340249","article-title":"Recent advances in the biochemistry of polyamines in eukaryotes","volume":"234","author":"Pegg","year":"1986","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib509","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1172\/JCI110793","article-title":"Electrical charge - its role in the pathogenesis and prevention of experimental membranous nephropathy in the rabbit","volume":"71","author":"Adler","year":"1983","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib510","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00005072-198409000-00004","article-title":"In situ formation of immune complexes in the choroid plexus of rats by sequential injection of a cationized antigen and unaltered antibodies","volume":"43","author":"Huang","year":"1984","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib511","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000183165","article-title":"In situ formation of subepithelial immune complexes in the rabbit glomerulus: requirement of a cationic antigen","volume":"36","author":"Ward","year":"1984","journal-title":"Nephron"},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120461_bib512","first-page":"662","article-title":"Charge-related alterations of the cerebral endothelium","volume":"49","author":"Nagy","year":"1983","journal-title":"Lab. Invest."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib513","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1172\/JCI111290","article-title":"The effects of polycations on vascular permeability in the rat. A proposed role for charge sites","volume":"73","author":"Vehaskari","year":"1984","journal-title":"J. Clin. Invest."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2020.120461_bib514","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drudis.2006.10.013","article-title":"Blood-brain barrier delivery","volume":"12","author":"Pardridge","year":"2007","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib515","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00401-014-1371-2","article-title":"Tau aggregation and its interplay with amyloid-beta","volume":"129","author":"Nisbet","year":"2015","journal-title":"Acta Neuropathol."},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120461_bib516","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat. Rev. Neurol."},{"issue":"2\u20133","key":"10.1016\/j.biomaterials.2020.120461_bib517","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbadis.2004.08.014","article-title":"Tau, tangles, and Alzheimer's disease","volume":"1739","author":"Binder","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib518","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1006\/bbrc.1993.2582","article-title":"Blood-brain barrier transport of circulating Alzheimer's amyloid beta","volume":"197","author":"Zlokovic","year":"1993","journal-title":"Biochem Bioph Res Co"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib519","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1006\/bbrc.1994.2825","article-title":"Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta","volume":"205","author":"Zlokovic","year":"1994","journal-title":"Biochem Bioph Res Co"},{"issue":"9","key":"10.1016\/j.biomaterials.2020.120461_bib520","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1073\/pnas.93.9.4229","article-title":"Glycoprotein 330\/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers","volume":"93","author":"Zlokovic","year":"1996","journal-title":"Proc. Natl. Acad. Sci-Biol."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib521","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1046\/j.1471-4159.1996.67020880.x","article-title":"Fate of cerebrospinal fluid-borne amyloid beta-peptide: rapid clearance into blood and appreciable accumulation by cerebral arteries","volume":"67","author":"Ghersi-Egea","year":"1996","journal-title":"J. Neurochem."},{"issue":"15","key":"10.1016\/j.biomaterials.2020.120461_bib522","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1073\/pnas.151261398","article-title":"Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease","volume":"98","author":"DeMattos","year":"2001","journal-title":"Proc. Natl. Acad. Sci-Biol."},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120461_bib523","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/78682","article-title":"Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease","volume":"6","author":"Bard","year":"2000","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib524","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/85525","article-title":"Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy","volume":"7","author":"Bacskai","year":"2001","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib525","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nm1234","article-title":"Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo","volume":"11","author":"Klyubin","year":"2005","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.biomaterials.2020.120461_bib526","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1523\/JNEUROSCI.3192-13.2014","article-title":"Passive immunization with tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles","volume":"34","author":"Castillo-Carranza","year":"2014","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib527","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/aps.2009.24","article-title":"Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases","volume":"30","author":"Dong","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"issue":"18","key":"10.1016\/j.biomaterials.2020.120461_bib528","doi-asserted-by":"crossref","first-page":"7315","DOI":"10.1073\/pnas.0702450104","article-title":"From the liver to the brain across the blood-brain barrier","volume":"104","author":"Teichberg","year":"2007","journal-title":"Proc. Natl. Acad. Sci-Biol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib529","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuroscience.2008.02.075","article-title":"Homeostasis of glutamate in brain fluids: an accelerated brain-to-blood efflux of excess glutamate is produced by blood glutamate scavenging and offers protection from neuropathologies","volume":"158","author":"Teichberg","year":"2009","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib530","doi-asserted-by":"crossref","DOI":"10.3390\/biology5040037","article-title":"How glutamate is managed by the blood-brain barrier","volume":"5","author":"Hawkins","year":"2016","journal-title":"Biology"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib531","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1471-4159.2003.01972.x","article-title":"Blood-mediated scavenging of cerebrospinal fluid glutamate","volume":"87","author":"Gottlieb","year":"2003","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib532","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.expneurol.2006.08.021","article-title":"Brain neuroprotection by scavenging blood glutamate","volume":"203","author":"Zlotnik","year":"2007","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib533","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s13311-012-0129-6","article-title":"The effect of blood glutamate scavengers oxaloacetate and pyruvate on neurological outcome in a rat model of subarachnoid hemorrhage","volume":"9","author":"Boyko","year":"2012","journal-title":"Neurotherapeutics"},{"issue":"10","key":"10.1016\/j.biomaterials.2020.120461_bib534","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1007\/s11064-012-0843-9","article-title":"Pharmacokinetics of glutamate-oxaloacetate transaminase and glutamate-pyruvate transaminase and their blood glutamate-lowering activity in naive rats","volume":"37","author":"Boyko","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biomaterials.2020.120461_bib535","doi-asserted-by":"crossref","first-page":"e992","DOI":"10.1038\/cddis.2013.507","article-title":"Human recombinant glutamate oxaloacetate transaminase 1 (GOT1) supplemented with oxaloacetate induces a protective effect after cerebral ischemia","volume":"5","author":"Perez-Mato","year":"2014","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.biomaterials.2020.120461_bib536","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1460-9568.2011.07864.x","article-title":"Pyruvate's blood glutamate scavenging activity contributes to the spectrum of its neuroprotective mechanisms in a rat model of stroke","volume":"34","author":"Boyko","year":"2011","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib537","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s12640-018-9961-8","article-title":"Blood-based glutamate scavengers reverse traumatic brain injury-induced synaptic plasticity disruption by decreasing glutamate level in hippocampus interstitial fluid, but not cerebral spinal fluid, in vivo","volume":"35","author":"Zhang","year":"2019","journal-title":"Neurotox. Res."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120461_bib538","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000382034","article-title":"Combined treatment of an amyotrophic lateral sclerosis rat model with recombinant GOT1 and oxaloacetic acid: a novel neuroprotective treatment","volume":"15","author":"Ruban","year":"2015","journal-title":"Neurodegener. Dis."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120461_bib539","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1471-4159.2003.01972.x","article-title":"Blood-mediated scavenging of cerebrospinal fluid glutamate","volume":"87","author":"Gottlieb","year":"2003","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120461_bib540","doi-asserted-by":"crossref","first-page":"10041","DOI":"10.3390\/ijms130810041","article-title":"Blood glutamate scavenging: insight into neuroprotection","volume":"13","author":"Leibowitz","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biomaterials.2020.120461_bib541","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/bs.apha.2014.06.002","article-title":"Delivery of chemotherapeutics across the blood-brain barrier: challenges and advances","volume":"71","author":"Doolittle","year":"2014","journal-title":"Adv. Pharmacol."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib542","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/00006123-199805000-00082","article-title":"Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means","volume":"42","author":"Kroll","year":"1998","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib543","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00685243","article-title":"Capillary junctions of the rat are not affected by osmotic opening of the blood-brain barrier","volume":"63","author":"Farrell","year":"1984","journal-title":"Acta Neuropathol."},{"issue":"17","key":"10.1016\/j.biomaterials.2020.120461_bib544","first-page":"4725","article-title":"Delivery of melanoma-associated immunoglobulin monoclonal antibody and Fab fragments to normal brain utilizing osmotic blood-brain barrier disruption","volume":"48","author":"Neuwelt","year":"1988","journal-title":"Canc. Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib545","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1227\/00006123-198509000-00004","article-title":"Osmotic blood-brain barrier modification: monoclonal antibody, albumin, and methotrexate delivery to cerebrospinal fluid and brain","volume":"17","author":"Neuwelt","year":"1985","journal-title":"Neurosurgery"},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120461_bib546","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/00006123-199805000-00082","article-title":"Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means","volume":"42","author":"Kroll","year":"1998","journal-title":"Neurosurgery"},{"issue":"11","key":"10.1016\/j.biomaterials.2020.120461_bib547","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11110568","article-title":"Improving in vivo brain delivery of monoclonal antibody using novel cyclic peptides","volume":"11","author":"Ulapane","year":"2019","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib548","first-page":"404","article-title":"Noninvasive brain delivery and efficacy of BDNF to stimulate neuroregeneration and suppression of disease relapse in EAE mice","volume":"17","author":"Kopec","year":"2020","journal-title":"Mol. Pharm."},{"issue":"12","key":"10.1016\/j.biomaterials.2020.120461_bib549","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1021\/acs.molpharmaceut.9b00763","article-title":"In vivo brain delivery and brain deposition of proteins with various sizes","volume":"16","author":"Ulapane","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2020.120461_bib550","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-3-319-66095-0_8","article-title":"Peptides and drug delivery","volume":"1030","author":"Ulapane","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib551","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/jps.24309","article-title":"Modulation of intercellular junctions by cyclic-ADT peptides as a method to reversibly increase blood-brain barrier permeability","volume":"104","author":"Laksitorini","year":"2015","journal-title":"J Pharm Sci-Us"},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120461_bib552","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1021\/mp400624v","article-title":"Modulation of blood-brain barrier permeability in mice using synthetic E-cadherin peptide","volume":"11","author":"On","year":"2014","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120461_bib553","doi-asserted-by":"crossref","first-page":"217","DOI":"10.7150\/ntno.19158","article-title":"Improving brain delivery of biomolecules via BBB modulation in mouse and rat: detection using MRI, NIRF, and mass spectrometry","volume":"1","author":"Ulapane","year":"2017","journal-title":"Nanotheranostics"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961220307079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961220307079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:08:24Z","timestamp":1758906504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961220307079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":553,"alternative-id":["S0142961220307079"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120461","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treating brain diseases using systemic parenterally-administered protein therapeutics: Dysfunction of the brain barriers and potential strategies","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120461","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120461"}}